
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Hereditary variants of unknown significance in African American women with breast cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCBAB67926532A33DAB6700380C51A3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9621418/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS ONE">
<meta name="citation_title" content="Hereditary variants of unknown significance in African American women with breast cancer">
<meta name="citation_author" content="J Tyson McDonald">
<meta name="citation_author_institution" content="Department of Radiation Medicine, Georgetown University School of Medicine, Washington, DC, United States of America">
<meta name="citation_author" content="Luisel J Ricks-Santi">
<meta name="citation_author_institution" content="Cancer Research Center, Hampton University, Hampton, VA, United States of America">
<meta name="citation_author_institution" content="Department of Pharmacotherapy and Translational Research, College of Medicine, University of Florida, Gainesville, FL, United States of America">
<meta name="citation_publication_date" content="2022 Oct 31">
<meta name="citation_volume" content="17">
<meta name="citation_issue" content="10">
<meta name="citation_firstpage" content="e0273835">
<meta name="citation_doi" content="10.1371/journal.pone.0273835">
<meta name="citation_pmid" content="36315513">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9621418/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9621418/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9621418/pdf/pone.0273835.pdf">
<meta name="description" content="Expanded implementation of genetic sequencing has precipitously increased the discovery of germline and somatic variants. The direct benefit of identifying variants in actionable genes may lead to risk reduction strategies such as increased ...">
<meta name="og:title" content="Hereditary variants of unknown significance in African American women with breast cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Expanded implementation of genetic sequencing has precipitously increased the discovery of germline and somatic variants. The direct benefit of identifying variants in actionable genes may lead to risk reduction strategies such as increased ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9621418/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9621418">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0273835"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0273835.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9621418%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9621418/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9621418/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9621418/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0273835" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2022 Oct 31;17(10):e0273835. doi: <a href="https://doi.org/10.1371/journal.pone.0273835" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0273835</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Hereditary variants of unknown significance in African American women with breast cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McDonald%20JT%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">J Tyson McDonald</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">J Tyson McDonald</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Medicine, Georgetown University School of Medicine, Washington, DC, United States of America</div>
<div>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McDonald%20JT%22%5BAuthor%5D" class="usa-link"><span class="name western">J Tyson McDonald</span></a>
</div>
</div>
<sup>1,</sup><sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ricks-Santi%20LJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Luisel J Ricks-Santi</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Luisel J Ricks-Santi</span></h3>
<div class="p">
<sup>2</sup>Cancer Research Center, Hampton University, Hampton, VA, United States of America</div>
<div class="p">
<sup>3</sup>Department of Pharmacotherapy and Translational Research, College of Medicine, University of Florida, Gainesville, FL, United States of America</div>
<div>Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ricks-Santi%20LJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Luisel J Ricks-Santi</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>‡,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Alvaro Galli</span><sup>4</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Department of Radiation Medicine, Georgetown University School of Medicine, Washington, DC, United States of America</div>
<div id="aff002">
<sup>2</sup>Cancer Research Center, Hampton University, Hampton, VA, United States of America</div>
<div id="aff003">
<sup>3</sup>Department of Pharmacotherapy and Translational Research, College of Medicine, University of Florida, Gainesville, FL, United States of America</div>
<div id="edit1">
<sup>4</sup>CNR, ITALY</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
<div class="fn" id="econtrib001"><p>‡ JTM and LJR are joint senior authors on this work.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>lrickssanti@cop.ufl.edu</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">J Tyson McDonald</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Luisel J Ricks-Santi</span></strong>: <span class="role">Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Alvaro Galli</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 Mar 17; Accepted 2022 Aug 17; Collection date 2022.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2022 McDonald, Ricks-Santi</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9621418  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36315513/" class="usa-link">36315513</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Expanded implementation of genetic sequencing has precipitously increased the discovery of germline and somatic variants. The direct benefit of identifying variants in actionable genes may lead to risk reduction strategies such as increased surveillance, prophylactic surgery, as well as lifestyle modifications to reduce morbidity and mortality. However, patients with African ancestry are more likely to receive inconclusive genetic testing results due to an increased number of variants of unknown significance decreasing the utility and impact on disease management and prevention. This study examines whole exome sequencing results from germline DNA samples in African American women with a family history of cancer including 37 cases that were diagnosed with breast cancer and 51 family members. Self-identified ancestry was validated and compared to the 1000 genomes population. The analysis of sequencing results was limited to 85 genes from three clinically available common genetic screening platforms. This target region had a total of 993 variants of which 6 (&lt;1%) were pathogenic or likely pathogenic, 736 (74.1%) were benign, and 170 (17.1%) were classified as a variant of unknown significance. There was an average of 3.4±1.8 variants with an unknown significance per individual and 85 of 88 individuals (96.6%) harbored at least one of these in the targeted genes. Pathogenic or likely pathogenic variants were only found in 6 individuals for the <em>BRCA1</em> (p.R1726fs, rs80357867), <em>BRCA2</em> (p.K589fs, rs397507606 &amp; p.L2805fs, rs397507402), <em>RAD50</em> (p.E995fs, rs587780154), <em>ATM</em> (p.V2424G, rs28904921), or <em>MUTYH</em> (p.G396D, rs36053993) genes. Strategies to functionally validate the remaining variants of unknown significance, especially in understudied and hereditary cancer populations, are greatly needed to increase the clinical utility and utilization of clinical genetic screening platforms to reduce cancer incidence and mortality.</p></section><section id="sec001"><h2 class="pmc_sec_title">Introduction</h2>
<p>Familial and hereditary breast cancer (BCa) makes up 20–30% and 5–10% of all breast cancers, respectively [<a href="#pone.0273835.ref001" class="usa-link" aria-describedby="pone.0273835.ref001">1</a>]. Many “actionable” genes have been discovered, such as <em>BRCA1</em> and <em>BRCA2</em> which confer the greatest risk of BCa, at 40–87% for <em>BRCA1</em> mutation carriers and 18–88% for <em>BRCA2</em> mutation carriers [<a href="#pone.0273835.ref002" class="usa-link" aria-describedby="pone.0273835.ref002">2</a>]. In adults, actionable genes are classified as those with deleterious mutation(s) whose phenotype results in a specific, defined medical recommendation(s). Thus, these genes inform patients and doctors in the proper deployment of risk reduction strategies such as early detection, prophylactic surgery, chemoprevention, lifestyle modifications, and treatment. The functional consequences of these genes must be supported by prior experimental evidence and when considered in treatment must improve an outcome(s) in terms of mortality or the avoidance of significant morbidity [<a href="#pone.0273835.ref003" class="usa-link" aria-describedby="pone.0273835.ref003">3</a>, <a href="#pone.0273835.ref004" class="usa-link" aria-describedby="pone.0273835.ref004">4</a>].</p>
<p>More recently, the clinical use of low-cost genetic sequencing in multiple genes, or gene panels, is increasing [<a href="#pone.0273835.ref005" class="usa-link" aria-describedby="pone.0273835.ref005">5</a>] due to the discovery of additional actionable genes revealed in the last 20 years. However, actionable genes such as <em>BRCA1</em> and <em>BRCA2</em> also harbor a myriad of genetic variants of unknown clinical significance (VUSs) hampering prevention and cancer management efforts, especially in African American (AA) women who report a higher frequency of VUS in <em>BRCA1/2</em> [<a href="#pone.0273835.ref006" class="usa-link" aria-describedby="pone.0273835.ref006">6</a>]. Not all genetic variants in actionable genes have clinical relevance and in fact, many variants are benign. Nevertheless, wide scale implementation of genetic testing has resulted in an increased observation of VUSs without documented clinical relevance limiting their clinical utility especially in diverse populations [<a href="#pone.0273835.ref007" class="usa-link" aria-describedby="pone.0273835.ref007">7</a>–<a href="#pone.0273835.ref011" class="usa-link" aria-describedby="pone.0273835.ref011">11</a>].</p>
<p>The discoveries of causative functional alleles have far-reaching implications for the early detection of cancer, cancer prevention efforts, and the elimination of cancer disparities. In the case of <em>BRCA1/2</em>, and other genes, there are specific guidelines for prevention, management and treatment of breast and ovarian cancer patients with pathogenic, disease-causing mutations. The role of <em>BRCA1/2</em> in therapeutic regimens has emerged based on the DNA repair of double stranded breaks. A synthetic strategy for cancer therapy has been developed in which DNA damaging chemotherapeutic agents that cause single-stranded breaks are being used in combination with poly-ADP ribose polymerase (PARP) inhibitors, which inhibit single-stranded DNA repair. This approach has been shown to be particularly effective in BRCA mutation carriers, as these tumors are unable to repair the double-stranded breaks [<a href="#pone.0273835.ref012" class="usa-link" aria-describedby="pone.0273835.ref012">12</a>–<a href="#pone.0273835.ref014" class="usa-link" aria-describedby="pone.0273835.ref014">14</a>] and may be the case for other cancer predisposition genes whose roles are overrepresented in DNA repair pathways. For example, PARP inhibitors appear to also have utility, although limited, in metastatic breast cancer and TNBC with <em>PALB2</em> mutations and somatic <em>BRCA1</em> mutations [<a href="#pone.0273835.ref015" class="usa-link" aria-describedby="pone.0273835.ref015">15</a>]. Remarkably, there are at least 3 clinical trials testing this therapeutic strategy in non-BRCA mutation carriers with deficient homologous recombinational repair: <a href="https://clinicaltrials.gov/ct2/show/NCT03344965" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03344965</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT03742895" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03742895</a> and <a href="https://clinicaltrials.gov/ct2/show/NCT03367689" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03367689</a>. Still, VUSs, even in actionable genes, hinders clinical decision making in patients undergoing genetic testing and can lead to significant distress in young and AA women [<a href="#pone.0273835.ref016" class="usa-link" aria-describedby="pone.0273835.ref016">16</a>]. This study will provide insight into the scope and identification of genetic variants with broad implications in familial BCa patients, especially in AA women.</p></section><section id="sec002"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec003"><h3 class="pmc_sec_title">DNA samples</h3>
<p>DNA samples were from the African American Familial Breast Cancer Study (AAFBC) [<a href="#pone.0273835.ref017" class="usa-link" aria-describedby="pone.0273835.ref017">17</a>–<a href="#pone.0273835.ref020" class="usa-link" aria-describedby="pone.0273835.ref020">20</a>] and the Breast Cancer Determinants in Women from Washington, DC study. The original study was approved by the Howard University Institutional Review Board (IRB97CC01). This study met the criteria for exemption as a secondary analysis of existing data was performed and the data were analyzed anonymously and was also approved by the Howard University Institutional Review Board (09-MED-86). These participants were recruited initially from AA women with a primary diagnosis of BCa and a family history of cancer. Additional participants were then recruited from their family members including first-degree, second-degree, and distant relatives in the same lineage. Eligibility for this study included meeting one or more of the following criteria: 1) having multiple cases (≥2) of breast or ovarian cancer in the family; 2) having early onset breast cancer (≤40 years old); 3) having bilateral breast cancer; 4) having breast and ovarian cancer in the same individual, or 5) having male breast cancer in the family. Positive family history was defined as having multiple cases (≥2) of breast or ovarian cancer in the same side of the family. A total of 88 individuals were selected for whole exome sequencing analysis. These individuals represent affected probands (n = 37) and/or their previously affected and/or unaffected family members (n = 51). Eleven cases reported family histories of other cancers including, but not limited to lung, colorectal, and uterine cancer. The mean age for the probands, unaffected family members and affected family members was 53.76±14.25, 48.80±16.45, and 41.2±8.67, respectively. DNA samples were examined by agarose gel electrophoresis to test for DNA degradation and potential contamination. DNA concentration was measured using a Qubit 2.0 Fluorometer (Thermo Fisher Science, Waltham, MA).</p></section><section id="sec004"><h3 class="pmc_sec_title">Whole exome sequencing (WES)</h3>
<p>The Agilent SureSelect Human All ExonV6 kit (Agilent Technologies, CA) was used to generate sequencing libraries following manufacturer’s recommendations. Products were purified using AMPure XP system (Beckman Coulter, Beverly, USA) and quantified using the Agilent high sensitivity DNA assay on the 2100 Bioanalyzer Instrument (Agilent, Santa Clara, CA). Sample libraries were sequenced using Illumina protocols by Novogene (Novogene Co., Ltd. Durham, NC). Data has been submitted to dbGAP (phs002977).</p></section><section id="sec005"><h3 class="pmc_sec_title">WES data processing, genomic copy number analysis, and variant calling</h3>
<p>Following quality control analysis, raw data fastq files were processed according to the Genome Analysis Toolkit’s (GATK) Best Practices workflow [<a href="#pone.0273835.ref021" class="usa-link" aria-describedby="pone.0273835.ref021">21</a>–<a href="#pone.0273835.ref023" class="usa-link" aria-describedby="pone.0273835.ref023">23</a>]. Briefly, reads were aligned to the hg38 reference genome using the Burrows-Wheeler Aligner v0.7.17 [<a href="#pone.0273835.ref024" class="usa-link" aria-describedby="pone.0273835.ref024">24</a>, <a href="#pone.0273835.ref025" class="usa-link" aria-describedby="pone.0273835.ref025">25</a>] followed by duplicate removal, base quality score recalibration, haplotype calling for variant identification using the joint calling process, and filtered using the variant quality score recalibration from GATK v4.1.4.1. Variants were limited to the target regions used for library preparation and the final set of variants were annotated using SNPeff with information from the NCBI’s ClinVar and dbSNP databases. Oncoplots and heatmaps were generated with maftools v2.2.10 [<a href="#pone.0273835.ref026" class="usa-link" aria-describedby="pone.0273835.ref026">26</a>] and pheatmap v1.0.12 respectively. Genomic copy number evaluation was performed with ExomeDepth [<a href="#pone.0273835.ref027" class="usa-link" aria-describedby="pone.0273835.ref027">27</a>]. Germline variants in the same target regions were also identified from AA (N = 174) or CA (N = 348) samples in the Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) data collection.</p></section><section id="sec006"><h3 class="pmc_sec_title">Estimation of genetic ancestry</h3>
<p>The study population was compared individuals with known ancestry from the 1000 Genomes Project dataset. Genotypes used were from the data release of phased biallelic SNP plus INDEL call sets for unrelated samples aligned to GRCh38 (version 3-12-2019 [<a href="#pone.0273835.ref028" class="usa-link" aria-describedby="pone.0273835.ref028">28</a>]). There were 2,548 samples from 26 populations representing the 5 superpopulations (AFR, African; AMR, Ad Mixed American; EAS, East Asian; EUR, European; SAS, South Asian). There were 10,512 exon coding variants in the current dataset that matched to the 1000 Genomes dataset. Following filtering with PLINK v1.9 [<a href="#pone.0273835.ref029" class="usa-link" aria-describedby="pone.0273835.ref029">29</a>] for variants with a &gt;10% minor allele frequency using a 50kb window that excluded variants in linkage, there were 645 variants used for principal component analysis (PCA). PCA was performed on the study population and 26 populations from the 1000 Genomes project by plotting the principle eigenvalue components to visualize clustering of similar ancestries [<a href="#pone.0273835.ref030" class="usa-link" aria-describedby="pone.0273835.ref030">30</a>, <a href="#pone.0273835.ref031" class="usa-link" aria-describedby="pone.0273835.ref031">31</a>]. Population ancestry admixture was performed on the study population and 4 populations from the 1000 Genomes dataset (CEU, ASW, YRI, and CHB) using the Bayesian clustering approach of the STRUCTURE v2.3.4 program [<a href="#pone.0273835.ref032" class="usa-link" aria-describedby="pone.0273835.ref032">32</a>]. From the previous set of 645 variants used in the PCA analysis, 579 variants were single-nucleotide variants that were used for admixture analysis. The estimation value for the number of populations (K) was set from 3 to 5 using a 10,000 burn-in followed by 20,000 iterations with 2 replicates each. There results were combined and plotted using the software package Clumpak [<a href="#pone.0273835.ref033" class="usa-link" aria-describedby="pone.0273835.ref033">33</a>].</p></section><section id="sec007"><h3 class="pmc_sec_title">Statistics</h3>
<p>Statistical differences in the total number of variants with a pathogenic clinical significance were made using an independent t-test. P-values less than 0.05 were considered significant.</p></section></section><section id="sec008"><h2 class="pmc_sec_title">Results</h2>
<section id="sec009"><h3 class="pmc_sec_title">Estimation of individual genetic ancestry</h3>
<p>DNA samples were previously collected from self-identified African American women with a primary diagnosis of BCa and a family history of cancer. Additional samples were collected from family members. A total of 88 DNA samples comprising of 37 probands and 51 family members were successfully analyzed using whole exome sequencing. Following data processing using the Genome Analysis Toolkit (GATK) Best Practices workflow [<a href="#pone.0273835.ref021" class="usa-link" aria-describedby="pone.0273835.ref021">21</a>–<a href="#pone.0273835.ref023" class="usa-link" aria-describedby="pone.0273835.ref023">23</a>], the subsequent variants were filtered to include exon targeted regions following annotation with current dbSNP and ClinVar databases.</p>
<p>Estimation of individual ancestry was performed using appropriate variants present in both the study population and the 1000 Genomes project database. First, the resulting variants were used to perform a principal component analysis (PCA). As expected, the self-identified AA women clustered closely with populations of African ancestry (<a href="#pone.0273835.g001" class="usa-link">Fig 1A–1C</a>). Second, the study population was compared to four populations (CHB, CEU, YRI, and ASW) using the admixture model from STRUCTURE to estimate genetic ancestry. Examining the results using a bar plot or ternary plot demonstrated that the study population displayed similar admixture to the ASW population (<a href="#pone.0273835.g001" class="usa-link">Fig 1D and 1E</a>). Thus, this population of women with African ancestry, BCa, and a familial history of cancer represents a unique dataset to study germline genetic variants that may predispose individuals to cancer.</p>
<figure class="fig xbox font-sm" id="pone.0273835.g001"><h4 class="obj_head">Fig 1. Estimation of individual genetic ancestry.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9621418_pone.0273835.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ece/9621418/2c2b60f0e645/pone.0273835.g001.jpg" loading="lazy" height="599" width="750" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0273835.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A-C) Principal component analysis (PCA) was used to visualize individual clustering compared to the 1000 Genomes Project 5 superpopulations. (D-E) STRUCTURE’s admixture model based on three ancestral populations (K = 3) was used to compare the study population to CEU, YRI, CHB, and ASW populations. The data is displayed using a (D) bar or (E) ternary plot.</p></figcaption></figure></section><section id="sec010"><h3 class="pmc_sec_title">Variants within clinical cancer screening panel</h3>
<p>While somatic and germline WES is gaining clinical utility, the use of targeted sequencing panels are widely available especially in the case of suspected hereditary cancers [<a href="#pone.0273835.ref034" class="usa-link" aria-describedby="pone.0273835.ref034">34</a>–<a href="#pone.0273835.ref038" class="usa-link" aria-describedby="pone.0273835.ref038">38</a>]. There were 85 unique genes targeting actionable variants in largely DNA-repair genes that were present on three commercially available clinical screening platforms from the Invitae Corporation [<a href="#pone.0273835.ref039" class="usa-link" aria-describedby="pone.0273835.ref039">39</a>], Ambry Genetics [<a href="#pone.0273835.ref040" class="usa-link" aria-describedby="pone.0273835.ref040">40</a>], and Myriad Genetics [<a href="#pone.0273835.ref041" class="usa-link" aria-describedby="pone.0273835.ref041">41</a>] (<a href="#pone.0273835.g002" class="usa-link">Fig 2A</a>). There were 28 genes (33%) in common with all 3 panels while 23 gene targets (27.1%) were unique to only one panel. Within these 85 targeted gene regions, there were 959 SNPs and 34 INDELs from the cohort of 88 AA women. These variants were examined for ClinVar annotated clinical significance as benign/likely benign, pathogenic/likely pathogenic, uncertain significance, or conflicting interpretations of pathogenicity (<a href="#pone.0273835.g002" class="usa-link">Fig 2B</a>). While 74.1% of the total variants were classified as benign or likely benign, there were 170 VUSs (17.1%) with an average of 3.4±1.8 VUSs per individual (<a href="#pone.0273835.g002" class="usa-link">Fig 2C</a>, <a href="#pone.0273835.s001" class="usa-link">S1</a> and <a href="#pone.0273835.s002" class="usa-link">S2</a> Tables). Detectable changes in genomic copy number were found in only 9 of 993 variants (0.01%) and only 2 of these variants were classified as a VUS (<a href="#pone.0273835.s002" class="usa-link">S2 Table</a>). Notably, 85 of 88 individuals (96.6%) had at least one germline VUS within these 85 clinically targeted genes.</p>
<figure class="fig xbox font-sm" id="pone.0273835.g002"><h4 class="obj_head">Fig 2. Variants in clinical cancer screening panel genes.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9621418_pone.0273835.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ece/9621418/d52e98fc58cb/pone.0273835.g002.jpg" loading="lazy" height="813" width="750" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0273835.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Overlap of Invitae, Ambry, and Myriad breast cancer/cancer panels resulting in 85 clinically targeted genes. (B) Classification of clinical significance in 959 SNPs and 34 INDELs in the 85 actionable genes from common clinical cancer screening panels. (C) Oncoplot of genes with one or more germline VUS found in 69 of 88 individuals.</p></figcaption></figure><p>To better understand and prioritize the VUS in this cohort, 9 <em>in silico</em> prediction algorithms were assembled. A consensus score was tallied for the most damaging prediction in each algorithm (<a href="#pone.0273835.g003" class="usa-link">Fig 3</a>). The <em>CHEK2</em> variant (H143R, rs587782300) had the highest consensus score that was predicted to be damaging in 8 of the 9 algorithms. This variant was first identified in women with hereditary ovarian cancer [<a href="#pone.0273835.ref042" class="usa-link" aria-describedby="pone.0273835.ref042">42</a>] and subsequently in AA women with invasive BCa [<a href="#pone.0273835.ref043" class="usa-link" aria-describedby="pone.0273835.ref043">43</a>] as well as those suspected of Lynch syndrome [<a href="#pone.0273835.ref044" class="usa-link" aria-describedby="pone.0273835.ref044">44</a>]. This variant is located in the forkhead-associated (FHA) functional domain of <em>CHEK2</em> and was found to impair DNA repair activity in yeast [<a href="#pone.0273835.ref042" class="usa-link" aria-describedby="pone.0273835.ref042">42</a>, <a href="#pone.0273835.ref045" class="usa-link" aria-describedby="pone.0273835.ref045">45</a>]. However, functional validation for the H143R variant in human models is lacking. The next highest consensus score predicted to be damaging in 7 of the 9 algorithms included variants in the <em>CDKN1B</em> (P35L, rs375297371) and <em>TSC2</em> (R1751H, rs373365980 &amp; D907Y, rs1287273870) genes. Functional studies in human models and epidemiological results in larger cancer cohorts are lacking for these VUSs. In mutant yeast cells, the <em>CDKN1B</em> variant did not affect binding to the VHL protein or affect the yeast growth rates [<a href="#pone.0273835.ref046" class="usa-link" aria-describedby="pone.0273835.ref046">46</a>] and the <em>TSC2</em> variants have not observed in published studies for its associated diseases. Thus, the identification in this cohort and <em>in silico</em> scoring results may assist to prioritize these VUSs for functional evaluation in experimental human models.</p>
<figure class="fig xbox font-sm" id="pone.0273835.g003"><h4 class="obj_head">Fig 3. <em>In silico</em> prediction scores for VUSs.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9621418_pone.0273835.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ece/9621418/19926c98069e/pone.0273835.g003.jpg" loading="lazy" height="201" width="750" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0273835.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>There were 170 VUSs with a clinical significance annotated as unknown (black) or with conflicting interpretation of pathogenicity (dark blue). A consensus score (top bar) was generated by totaling the number predictive algorithms with a deleterious/damaging or equivalent score (red).</p></figcaption></figure><p>There is no gold standard to classify VUSs using <em>in silico</em> results which may overlook unpredicted consequences. For instance, the clinical significance for three VUSs with conflicting interpretations of pathogenicity also had low consensus scores but epidemiolocal studies indicated a pathogenic or likely pathogenic status (<a href="#pone.0273835.t001" class="usa-link">Table 1</a>). Reports have linked the <em>HOXB13</em> germline variant (G84E, rs138213197) to an increased risk of prostate cancer in men of European descent [<a href="#pone.0273835.ref047" class="usa-link" aria-describedby="pone.0273835.ref047">47</a>, <a href="#pone.0273835.ref048" class="usa-link" aria-describedby="pone.0273835.ref048">48</a>] and also found an increase in overall cancer risk in a pooled analysis of 25 epidemiological studies with 145,257 participates [<a href="#pone.0273835.ref049" class="usa-link" aria-describedby="pone.0273835.ref049">49</a>]. Though, there is also inconclusive evidence for prostate cancer reported for this variant. The in-frame insertion in the <em>FH</em> gene (N478KN, rs367543046) was recently found in 24 of individuals with various cancers and 11 individuals with renal cell carcinoma from a pool of 7,571 patients [<a href="#pone.0273835.ref050" class="usa-link" aria-describedby="pone.0273835.ref050">50</a>], however a significant association of the variant to cancer was not found. Lastly, the <em>CHEK2</em> gene variant (E239K, rs121908702) was initially identified in men with prostate cancer [<a href="#pone.0273835.ref051" class="usa-link" aria-describedby="pone.0273835.ref051">51</a>] but has also had conflicting association with cases [<a href="#pone.0273835.ref052" class="usa-link" aria-describedby="pone.0273835.ref052">52</a>] and controls [<a href="#pone.0273835.ref053" class="usa-link" aria-describedby="pone.0273835.ref053">53</a>] in two separate breast cancer cohorts. Interestingly, <em>in vitro</em> studies did result in an intermediate reduction of <em>CHEK2</em> kinase activity [<a href="#pone.0273835.ref053" class="usa-link" aria-describedby="pone.0273835.ref053">53</a>]. While these three variants are classified with uncertain significance or conflicting interpretations of pathogenicity, it may be necessary to examine a larger cohort of African American women with cancer to confirm a deleterious association specifically in this population.</p>
<section class="tw xbox font-sm" id="pone.0273835.t001"><h4 class="obj_head">Table 1. Pathogenic or likely pathogenic variants from the targeted clinical cancer screening genes.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Gene</th>
<th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">RSID</th>
<th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">REF</th>
<th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">ALT</th>
<th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Consequence</th>
<th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Proband or Family Member</th>
<th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Clinical Significance</th>
</tr></thead>
<tbody>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>HOXB13</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs138213197</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">C</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">G84E; Missense</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Proband</td>
<td align="left" rowspan="3" style="background-color:#FFFFFF" colspan="1">Conflicting interpretation of pathogenicity</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>FH</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs367543046</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">A</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">A<strong>TTT</strong>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">N478KN; In-frame Insertion</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Family Member</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>CHEK2</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs121908702</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">G</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">A</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">E239K, Missense</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Family Member</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>ATM</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs28904921</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">G</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">V2424G; Missense</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Proband</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF" colspan="1">Likely Pathogenic/ Pathogenic</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>MUTYH</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs36053993</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">C</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">G396D; Missense</td>
<td align="left" rowspan="1" colspan="1">Family Member</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs80357867</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T<strong>CTTT</strong>C</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">TC</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">R1726fs; Frameshift</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Proband</td>
<td align="left" rowspan="4" style="background-color:#FFFFFF" colspan="1">Pathogenic</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs397507606</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T<strong>AA</strong>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">K589fs; Frameshift</td>
<td align="left" rowspan="1" colspan="1">Family Member</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs397507402</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T<strong>TA</strong>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">L2805fs; Frameshift</td>
<td align="left" rowspan="1" colspan="1">Proband</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">
<em>RAD50</em>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">rs587780154</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">C<strong>AAAG</strong>
</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">C</td>
<td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">E995fs; Frameshift</td>
<td align="left" rowspan="1" colspan="1">Family Member</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0273835.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>There were only six variants with a likely pathogenic or pathogenic clinical significance that were uncovered in our hereditary cohort (<a href="#pone.0273835.t001" class="usa-link">Table 1</a>). The <em>ATM</em> variant (rs28904921) was recently compared to other pathogenic missense or truncating variants in the <em>ATM</em> gene in a large cohort of 627,742 hereditary cancer patients and found a higher increased risk of invasive ductal BCa (OR 3.76, 95% CI 2.76–5.21) for carriers of this variant [<a href="#pone.0273835.ref054" class="usa-link" aria-describedby="pone.0273835.ref054">54</a>]. The <em>MUTYH</em> gene variant (rs36053993) has been well described as a pathogenic variant in patients causing adenomatous polyposis and colorectal cancer [<a href="#pone.0273835.ref055" class="usa-link" aria-describedby="pone.0273835.ref055">55</a>–<a href="#pone.0273835.ref057" class="usa-link" aria-describedby="pone.0273835.ref057">57</a>] through a reduction of DNA binding and glycosylase activity [<a href="#pone.0273835.ref058" class="usa-link" aria-describedby="pone.0273835.ref058">58</a>, <a href="#pone.0273835.ref059" class="usa-link" aria-describedby="pone.0273835.ref059">59</a>]. There were two pathogenic variants identified in the <em>BRCA2</em> gene and one in each of the <em>BRCA1</em> and <em>RAD50</em> genes all of which resulted in a frameshift and truncated protein. The <em>BRCA1</em> variant (rs80357867) was originally identified in AA families with early onset BCa [<a href="#pone.0273835.ref060" class="usa-link" aria-describedby="pone.0273835.ref060">60</a>]. Since then, a number of studies have since identified this variant in American individuals [<a href="#pone.0273835.ref043" class="usa-link" aria-describedby="pone.0273835.ref043">43</a>, <a href="#pone.0273835.ref061" class="usa-link" aria-describedby="pone.0273835.ref061">61</a>, <a href="#pone.0273835.ref062" class="usa-link" aria-describedby="pone.0273835.ref062">62</a>] as well as those that are inhabitants of Slovenia [<a href="#pone.0273835.ref063" class="usa-link" aria-describedby="pone.0273835.ref063">63</a>], Brazil [<a href="#pone.0273835.ref064" class="usa-link" aria-describedby="pone.0273835.ref064">64</a>], Trinidad and Tobago [<a href="#pone.0273835.ref065" class="usa-link" aria-describedby="pone.0273835.ref065">65</a>], and Germany [<a href="#pone.0273835.ref066" class="usa-link" aria-describedby="pone.0273835.ref066">66</a>]. More recently, this variant was also identified in a cohort of 615 pediatric Rhabdomyosarcoma patients [<a href="#pone.0273835.ref067" class="usa-link" aria-describedby="pone.0273835.ref067">67</a>]. Both <em>BRCA2</em> variants (rs397507606 and rs397507402) were originally identified in a study of AA women with familial and early onset cases of breast and/or ovarian cancer [<a href="#pone.0273835.ref018" class="usa-link" aria-describedby="pone.0273835.ref018">18</a>]. The RAD50 frameshift variant (rs587780154) has been linked to familial BCa and Nijimegen breakage syndrome [<a href="#pone.0273835.ref068" class="usa-link" aria-describedby="pone.0273835.ref068">68</a>, <a href="#pone.0273835.ref069" class="usa-link" aria-describedby="pone.0273835.ref069">69</a>].</p>
<p>Finally, a comparison to the number of pathogenic variants in these 85 clinically targeted genes found in AA and CA women in the Cancer Genome Atlas (TCGA) Breast Invasive Carcinoma (BRCA) dataset was performed. There were no significance differences in the number of pathogenic variants found in the TCGA AA population and our hereditary cohort. However, there were approximately 3 times as many pathogenic variants identified in the TCGA individuals with CA ancestry (N = 348) compared to TCGA AA ancestry (N = 174; p-value = 0.0004) or individuals examined in this study (N = 88; p-value = 0.003). Although evaluation of the six damaging variants revealed significant links to an increase in cancer risk, this comparison demonstrates a potentially limited utility of targeted multi-gene panels in individuals with AA ancestry.</p></section></section><section id="sec011"><h2 class="pmc_sec_title">Discussion</h2>
<p>There is a striking lack of diversity as well as an underreporting of race as a demographic variable in genomic sequencing studies [<a href="#pone.0273835.ref070" class="usa-link" aria-describedby="pone.0273835.ref070">70</a>]. Of the published genome-wide association studies to identify genes associated with predisposition to BCa, few included women of African descent and even fewer have been done in AA families [<a href="#pone.0273835.ref017" class="usa-link" aria-describedby="pone.0273835.ref017">17</a>, <a href="#pone.0273835.ref043" class="usa-link" aria-describedby="pone.0273835.ref043">43</a>, <a href="#pone.0273835.ref071" class="usa-link" aria-describedby="pone.0273835.ref071">71</a>]. Therefore, the objective of this study was characterize genetic variants in 85 clinically actionable genes in a high-risk AA familial BCa cohort. Of the variants identified in those genes, the majority (74.1%) were benign, while 17.1% were VUSs or had conflicting pathogenicity. Each individual averaged approximately 3.4 (±1.8) VUSs, and all but 3 individuals had at least 1 VUS. Remarkably, only 4 pathogenic and 2 likely pathogenic variants were identified in our familial BCa cohort demonstrating a significant need to improve the clinical utility of genetic/genomic testing in diverse populations.</p>
<p>Compared to Caucasian (CA) women, AA women with BCa are often diagnosed at a younger age, have higher grade tumors, have a higher frequency of triple negative BCa, and have tumors that are more lethal with less successful treatment options (reviewed by Newman <em>et al</em>. [<a href="#pone.0273835.ref072" class="usa-link" aria-describedby="pone.0273835.ref072">72</a>, <a href="#pone.0273835.ref073" class="usa-link" aria-describedby="pone.0273835.ref073">73</a>]). These are characteristics consistent with genetic predisposition, thus identifying the genes that predispose AA women to BCa could improve outcomes in a subset of AA BCa cases. Additionally, the identification of actionable genetic variants predisposing more than 5–10% of all BCa cases also guides the management and treatment of cancer in those patients testing positive for pathogenic germline or somatic variants in any of the panel of 85 actionable genes examined in this study. Because the majority of genes found in these panels are within DNA repair pathways, therapeutics that exploit DNA repair deficiencies, such as PARP inhibitors, have become successful strategies for patients diagnosed with hereditary breast and ovarian cancer. A recent trial of one PARP inhibitor demonstrated partial response or stable disease in breast, ovarian and prostate cancer subjects [<a href="#pone.0273835.ref074" class="usa-link" aria-describedby="pone.0273835.ref074">74</a>]. Importantly, triple negative BCa is often associated with mutations in DNA repair genes such as <em>BRCA1</em>, making the therapeutic targeting of the pathway a viable option for the difficult to treat tumor type [<a href="#pone.0273835.ref015" class="usa-link" aria-describedby="pone.0273835.ref015">15</a>].</p>
<p>Wide scale implementation of genetic counseling has caused the exponential growth of clinical genetic testing and unintended discoveries of germline variants and VUSs without documented clinical relevance resulting in inconclusive findings. Within actionable genes are a myriad of variants whose function remains unknown. Although VUSs exist for all populations, the prevalence of VUS is significantly higher in patients with African ancestry. Sequencing results from a multi-center study in Florida, Arizona, New York and Wisconsin using the Invitae Multi-Cancer panel on 2,571 CAs and 110 AAs with solid tumors observed similar pathogenic variants (13.3% in CAs; 12.7% in AAs) while VUSs were substantially higher in AAs (46.1% in CAs; 65.5% in AAs) [<a href="#pone.0273835.ref075" class="usa-link" aria-describedby="pone.0273835.ref075">75</a>]. Tatieni <em>et al</em>. [<a href="#pone.0273835.ref011" class="usa-link" aria-describedby="pone.0273835.ref011">11</a>] and Roberts <em>et al</em>. [<a href="#pone.0273835.ref010" class="usa-link" aria-describedby="pone.0273835.ref010">10</a>] also found a reduced likelihood of pathogenic variants in AAs compared to non-Hispanic whites while both studies confirmed the higher frequency of VUS in AAs. In a smaller study, Bishop et al. also demonstrated that AA breast cases were more than 2.5 times more likely to carry at least 1 VUS (40% in AAs vs. 14.5% in CAs). Conversely, using publicly available data, Ndugga-Kabuye <em>et al</em>. [<a href="#pone.0273835.ref008" class="usa-link" aria-describedby="pone.0273835.ref008">8</a>] demonstrated that AA patients with a family history of cancer had a slightly higher frequency of pathogenic and likely pathogenic variants compared to CAs. Our findings provide further support that AAs with family histories of cancer will present with a lower identification of pathogenic variants along with a high number of clinical VUSs, thus limiting the clinical utility of cancer genomic panels in the group. While there is significant utility for the use of genetics and genomics to identify women at risk for BCa that may benefit from early detection and prevention strategies, AAs will have a reduced benefit from genomic cancer panel testing due to the high number of VUSs. Additionally, VUSs present significant challenges in the counseling of patients and their families regarding the appropriate management for cancer risks. The limited utility may be a result of reduced inclusion of data from diverse populations and the limit in tools that allow the timely functionalization of variants of unknown clinical significance.</p>
<p>Attempts to classify VUSs have been limited. Recently, 138,342 eligible individuals in the Ambry Genetics patient database were examined for <em>BRCA1/2</em> variant reclassification based on personal and family history of cancer [<a href="#pone.0273835.ref076" class="usa-link" aria-describedby="pone.0273835.ref076">76</a>]. The results from 2,383 <em>BRCA1/2</em> variants indicated 45 variants were in favor of pathogenicity while 150 were against. However, only 177 (7.4%) of these total variants were observed in 5 or more individual probands. It is notable, however, that the American College of Medical Genetics and Genomics (ACMG), Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists have provided guidance and recommendations for the classification of variants [<a href="#pone.0273835.ref077" class="usa-link" aria-describedby="pone.0273835.ref077">77</a>, <a href="#pone.0273835.ref078" class="usa-link" aria-describedby="pone.0273835.ref078">78</a>]. ACMG’s 5-tier system ranging from benign to pathogenic, evaluates the following criteria: population data, computational and predictive data, functional data, segregation data, de novo data, allelic data, other database and other data. The latter organizations, combined benign and likely benign variants resulting in a similar 4-tier system. Using these guidelines, several studies have reclassified <em>BRCA1</em> and <em>BRCA2</em> variants in Asian populations [<a href="#pone.0273835.ref079" class="usa-link" aria-describedby="pone.0273835.ref079">79</a>–<a href="#pone.0273835.ref081" class="usa-link" aria-describedby="pone.0273835.ref081">81</a>]. Given that that a positive family history increases the likelihood of variant reclassification, our goal is to use the ACMG guidelines to reclassify variants at high frequency in our high-risk BCa patients as reclassifications have a high potential for clinical impact often altering the clinical management of patients [<a href="#pone.0273835.ref082" class="usa-link" aria-describedby="pone.0273835.ref082">82</a>]. For example, Turner <em>et al</em>. showed that with the reclassification of 142 variants, clinical impact changed for 11.3% of those patients [<a href="#pone.0273835.ref083" class="usa-link" aria-describedby="pone.0273835.ref083">83</a>]. For many of those patients, variant reclassification resulted in an upgrade in reporting category (<em>i</em>.<em>e</em>. VUS to likely pathogenic) and altered clinical management, such as recommendations for organ surveillance, survey or cascade testing which tests family members for resulting variants.</p>
<p>Well established <em>in vitro</em> or <em>in vivo</em> functional studies demonstrating a damaging effect on protein function also provide evidence for support of pathogenicity that meets the ACMG guidelines. Functional characterization of variants in <em>BRCA1</em> and <em>BRCA2</em> is an established area and assays have been performed to test the impact of variants on ubiquitin ligase activity, transcription activation, protease sensitivity assays, and PARP inhibitor sensitivity assays as read-outs (reviewed by Monteiro <em>et al</em>. [<a href="#pone.0273835.ref084" class="usa-link" aria-describedby="pone.0273835.ref084">84</a>]). More recently, <em>PALB2</em> has been the subject of functional characterization given its more recent association with hereditary breast and ovarian cancer after its incorporation in early BCa genomic panels. Boonen <em>et al</em>. [<a href="#pone.0273835.ref085" class="usa-link" aria-describedby="pone.0273835.ref085">85</a>] and Wiltshire <em>et al</em>. [<a href="#pone.0273835.ref086" class="usa-link" aria-describedby="pone.0273835.ref086">86</a>] have developed a high-throughput <em>in vitro</em> CRISPR and reporter protocols that allow for the simultaneous screen of multiple VUSs using PARP inhibitor cytotoxic assays, DNA repair assays, and G2/M cell cycle checkpoint assays. CRISPR-based assays have more recently be utilized for the functional reclassification of <em>BRCA1</em> [<a href="#pone.0273835.ref087" class="usa-link" aria-describedby="pone.0273835.ref087">87</a>]. Finally, a recent pan-cancer analysis of clinically actionable oncogenic driver genes in the Cancer Genome Atlas (TCGA) was performed [<a href="#pone.0273835.ref088" class="usa-link" aria-describedby="pone.0273835.ref088">88</a>]. From over 9,000 tumor samples in 33 cancer types, they found 57% of tumors harbor actionable variants and were able to functionally validate 39 of 46 variants using two cell lines in survival and growth assays for carcinogenesis. The use of functional assays provide a promising step forward in identifying and verifying variants influencing tumor progression.</p></section><section id="sec012"><h2 class="pmc_sec_title">Conclusions</h2>
<p>The limited association of VUSs as well as time consuming and limited functional testing of VUSs with genetically defined cancer syndromes in large next generation sequencing data requires an innovative and high-throughput functional genomics approach. The successful identification and evaluation of VUSs may improve the deployment of personalized cancer prevention and treatment options for women with BCa. With an improvement in the classification of actionable variants, a greater understanding of the risk profile in all populations may be better understood and result in a novel intervention targeted approach to improve patient outcomes.</p></section><section id="sec013"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0273835.s001"><div class="caption p">
<span>S1 Table. Variants with an unknown significance or conflicting interpretation of clinical significance.</span><p>VUSs (N = 170) from the targeted regions of 85 genes with a tallied consensus score for 9 <em>in silico</em> prediction algorithms. The review status definition was provided by ClinVar as follows: (3) reviewed by expert panel, (2) two or more submitters with assertion criteria and evidence provided the same interpretation, or (1) multiple submitters provided assertion criteria and evidence but there are conflicting interpretations.</p>
<p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9621418/bin/pone.0273835.s001.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (22.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0273835.s002"><div class="caption p">
<span>S2 Table. Allele frequencies for all the variants found in the targeted regions of 85 genes (N = 993).</span><p>The total and population specific allele frequencies (AF) for the current study (N = 88), 1000 Genomes Project, NHLBI GO Exome Sequencing Project (ESP), and Genome Aggregation Database (gnomAD) are shown. Genomic copy number analysis (gCNV) was calculated using ExomeDepth.</p>
<p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9621418/bin/pone.0273835.s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (199.3KB, xlsx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The results published here are in part based upon data generated by the TCGA Research Network: <a href="https://www.cancer.gov/tcga" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cancer.gov/tcga</a>.</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>All relevant data are within the paper and its <a href="#sec013" class="usa-link">Supporting Information</a> files. Exome data were also deposited in dbGAP (phs002977).</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported by the Division of Cancer Epidemiology and Genetics, National Cancer Institute, R15CA239100, Dr. Luisel J Ricks-Santi, Dr. J. Tyson McDonald.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0273835.ref001">
<span class="label">1.</span><cite>Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85. doi: 10.1056/NEJM200007133430201
</cite> [<a href="https://doi.org/10.1056/NEJM200007133430201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10891514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Environmental%20and%20heritable%20factors%20in%20the%20causation%20of%20cancer%E2%80%94analyses%20of%20cohorts%20of%20twins%20from%20Sweden,%20Denmark,%20and%20Finland&amp;author=P%20Lichtenstein&amp;author=NV%20Holm&amp;author=PK%20Verkasalo&amp;author=A%20Iliadou&amp;author=J%20Kaprio&amp;volume=343&amp;issue=2&amp;publication_year=2000&amp;pages=78-85&amp;pmid=10891514&amp;doi=10.1056/NEJM200007133430201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref002">
<span class="label">2.</span><cite>Engel C, Fischer C. Breast cancer risks and risk prediction models. Breast Care (Basel).
2015;10(1):7–12. doi: 10.1159/000376600
</cite> [<a href="https://doi.org/10.1159/000376600" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4395818/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25960719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Care%20(Basel).&amp;title=Breast%20cancer%20risks%20and%20risk%20prediction%20models&amp;author=C%20Engel&amp;author=C%20Fischer&amp;volume=10&amp;issue=1&amp;publication_year=2015&amp;pages=7-12&amp;pmid=25960719&amp;doi=10.1159/000376600&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref003">
<span class="label">3.</span><cite>MacArthur DG, Manolio TA, Dimmock DP, Rehm HL, Shendure J, Abecasis GR, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508(7497):469–76. doi: 10.1038/nature13127
</cite> [<a href="https://doi.org/10.1038/nature13127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4180223/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24759409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Guidelines%20for%20investigating%20causality%20of%20sequence%20variants%20in%20human%20disease&amp;author=DG%20MacArthur&amp;author=TA%20Manolio&amp;author=DP%20Dimmock&amp;author=HL%20Rehm&amp;author=J%20Shendure&amp;volume=508&amp;issue=7497&amp;publication_year=2014&amp;pages=469-76&amp;pmid=24759409&amp;doi=10.1038/nature13127&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref004">
<span class="label">4.</span><cite>Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, et al. Actionable, pathogenic incidental findings in 1,000 participants’ exomes. Am J Hum Genet. 2013;93(4):631–40. doi: 10.1016/j.ajhg.2013.08.006
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2013.08.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3791261/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24055113/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Actionable,%20pathogenic%20incidental%20findings%20in%201,000%20participants%E2%80%99%20exomes&amp;author=MO%20Dorschner&amp;author=LM%20Amendola&amp;author=EH%20Turner&amp;author=PD%20Robertson&amp;author=BH%20Shirts&amp;volume=93&amp;issue=4&amp;publication_year=2013&amp;pages=631-40&amp;pmid=24055113&amp;doi=10.1016/j.ajhg.2013.08.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref005">
<span class="label">5.</span><cite>Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, et al. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer. JAMA Oncol. 2018;4(8):1066–72. doi: 10.1001/jamaoncol.2018.0644
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2018.0644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6143044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29801090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Uptake,%20Results,%20and%20Outcomes%20of%20Germline%20Multiple-Gene%20Sequencing%20After%20Diagnosis%20of%20Breast%20Cancer&amp;author=AW%20Kurian&amp;author=KC%20Ward&amp;author=AS%20Hamilton&amp;author=DM%20Deapen&amp;author=P%20Abrahamse&amp;volume=4&amp;issue=8&amp;publication_year=2018&amp;pages=1066-72&amp;pmid=29801090&amp;doi=10.1001/jamaoncol.2018.0644&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref006">
<span class="label">6.</span><cite>Kurian AW. BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications.
Curr Opin Obstet Gynecol. 2010;22(1):72–8. doi: 10.1097/GCO.0b013e328332dca3
</cite> [<a href="https://doi.org/10.1097/GCO.0b013e328332dca3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19841585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Obstet%20Gynecol&amp;title=BRCA1%20and%20BRCA2%20mutations%20across%20race%20and%20ethnicity:%20distribution%20and%20clinical%20implications.&amp;author=AW%20Kurian&amp;volume=22&amp;issue=1&amp;publication_year=2010&amp;pages=72-8&amp;pmid=19841585&amp;doi=10.1097/GCO.0b013e328332dca3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref007">
<span class="label">7.</span><cite>Bishop MR, Omeler-Fenaud SM, Huskey ALW, Merner ND. Gene panel screening for insight towards breast cancer susceptibility in different ethnicities. PLoS One. 2020;15(8):e0238295. doi: 10.1371/journal.pone.0238295
</cite> [<a href="https://doi.org/10.1371/journal.pone.0238295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7458311/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32866190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Gene%20panel%20screening%20for%20insight%20towards%20breast%20cancer%20susceptibility%20in%20different%20ethnicities&amp;author=MR%20Bishop&amp;author=SM%20Omeler-Fenaud&amp;author=ALW%20Huskey&amp;author=ND%20Merner&amp;volume=15&amp;issue=8&amp;publication_year=2020&amp;pages=e0238295&amp;pmid=32866190&amp;doi=10.1371/journal.pone.0238295&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref008">
<span class="label">8.</span><cite>Ndugga-Kabuye MK, Issaka RB. Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European. Fam Cancer.
2019;18(4):465–9. doi: 10.1007/s10689-019-00144-6
</cite> [<a href="https://doi.org/10.1007/s10689-019-00144-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6785397/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31531760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam%20Cancer.&amp;title=Inequities%20in%20multi-gene%20hereditary%20cancer%20testing:%20lower%20diagnostic%20yield%20and%20higher%20VUS%20rate%20in%20individuals%20who%20identify%20as%20Hispanic,%20African%20or%20Asian%20and%20Pacific%20Islander%20as%20compared%20to%20European&amp;author=MK%20Ndugga-Kabuye&amp;author=RB%20Issaka&amp;volume=18&amp;issue=4&amp;publication_year=2019&amp;pages=465-9&amp;pmid=31531760&amp;doi=10.1007/s10689-019-00144-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref009">
<span class="label">9.</span><cite>Pal T, Bonner D, Kim J, Monteiro AN, Kessler L, Royer R, et al. Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics. Breast J.
2013;19(2):189–92. doi: 10.1111/tbj.12083
</cite> [<a href="https://doi.org/10.1111/tbj.12083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23320992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20J.&amp;title=Early%20onset%20breast%20cancer%20in%20a%20registry-based%20sample%20of%20African-american%20women:%20BRCA%20mutation%20prevalence,%20and%20other%20personal%20and%20system-level%20clinical%20characteristics&amp;author=T%20Pal&amp;author=D%20Bonner&amp;author=J%20Kim&amp;author=AN%20Monteiro&amp;author=L%20Kessler&amp;volume=19&amp;issue=2&amp;publication_year=2013&amp;pages=189-92&amp;pmid=23320992&amp;doi=10.1111/tbj.12083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref010">
<span class="label">10.</span><cite>Roberts ME, Susswein LR, Janice Cheng W, Carter NJ, Carter AC, Klein RT, et al. Ancestry-specific hereditary cancer panel yields: Moving toward more personalized risk assessment. J Genet Couns. 2020;29(4):598–606. doi: 10.1002/jgc4.1257
</cite> [<a href="https://doi.org/10.1002/jgc4.1257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32227564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Genet%20Couns&amp;title=Ancestry-specific%20hereditary%20cancer%20panel%20yields:%20Moving%20toward%20more%20personalized%20risk%20assessment&amp;author=ME%20Roberts&amp;author=LR%20Susswein&amp;author=W%20Janice%20Cheng&amp;author=NJ%20Carter&amp;author=AC%20Carter&amp;volume=29&amp;issue=4&amp;publication_year=2020&amp;pages=598-606&amp;pmid=32227564&amp;doi=10.1002/jgc4.1257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref011">
<span class="label">11.</span><cite>Tatineni S, Tarockoff M, Abdallah N, Purrington KS, Assad H, Reagle R, et al. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center. Cancer Med. 2022.</cite> [<a href="https://doi.org/10.1002/cam4.4541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8921894/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35040284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Med&amp;title=Racial%20and%20ethnic%20variation%20in%20multigene%20panel%20testing%20in%20a%20cohort%20of%20BRCA1/2-negative%20individuals%20who%20had%20genetic%20testing%20in%20a%20large%20urban%20comprehensive%20cancer%20center&amp;author=S%20Tatineni&amp;author=M%20Tarockoff&amp;author=N%20Abdallah&amp;author=KS%20Purrington&amp;author=H%20Assad&amp;publication_year=2022&amp;pmid=35040284&amp;doi=10.1002/cam4.4541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref012">
<span class="label">12.</span><cite>Oldenburg RA, Meijers-Heijboer H, Cornelisse CJ, Devilee P. Genetic susceptibility for breast cancer: how many more genes to be found?
Crit Rev Oncol Hematol.
2007;63(2):125–49. doi: 10.1016/j.critrevonc.2006.12.004
</cite> [<a href="https://doi.org/10.1016/j.critrevonc.2006.12.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17498966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Rev%20Oncol%20Hematol.&amp;title=Genetic%20susceptibility%20for%20breast%20cancer:%20how%20many%20more%20genes%20to%20be%20found?&amp;author=RA%20Oldenburg&amp;author=H%20Meijers-Heijboer&amp;author=CJ%20Cornelisse&amp;author=P%20Devilee&amp;volume=63&amp;issue=2&amp;publication_year=2007&amp;pages=125-49&amp;pmid=17498966&amp;doi=10.1016/j.critrevonc.2006.12.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref013">
<span class="label">13.</span><cite>Ewing A, Thompson N, Ricks-Santi L. Strategies for enrollment of African Americans into cancer genetic studies. J Cancer Educ. 2015;30(1):108–15. doi: 10.1007/s13187-014-0669-z
</cite> [<a href="https://doi.org/10.1007/s13187-014-0669-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4254900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24882437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Educ&amp;title=Strategies%20for%20enrollment%20of%20African%20Americans%20into%20cancer%20genetic%20studies&amp;author=A%20Ewing&amp;author=N%20Thompson&amp;author=L%20Ricks-Santi&amp;volume=30&amp;issue=1&amp;publication_year=2015&amp;pages=108-15&amp;pmid=24882437&amp;doi=10.1007/s13187-014-0669-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref014">
<span class="label">14.</span><cite>Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013;152(5):1173–83. doi: 10.1016/j.cell.2013.02.022
</cite> [<a href="https://doi.org/10.1016/j.cell.2013.02.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3664290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23452860/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Repurposing%20CRISPR%20as%20an%20RNA-guided%20platform%20for%20sequence-specific%20control%20of%20gene%20expression&amp;author=LS%20Qi&amp;author=MH%20Larson&amp;author=LA%20Gilbert&amp;author=JA%20Doudna&amp;author=JS%20Weissman&amp;volume=152&amp;issue=5&amp;publication_year=2013&amp;pages=1173-83&amp;pmid=23452860&amp;doi=10.1016/j.cell.2013.02.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref015">
<span class="label">15.</span><cite>Tung NM, Robson ME, Ventz S, Santa-Maria CA, Nanda R, Marcom PK, et al. TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. J Clin Oncol. 2020;38(36):4274–82. doi: 10.1200/JCO.20.02151
</cite> [<a href="https://doi.org/10.1200/JCO.20.02151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33119476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=TBCRC%20048:%20Phase%20II%20Study%20of%20Olaparib%20for%20Metastatic%20Breast%20Cancer%20and%20Mutations%20in%20Homologous%20Recombination-Related%20Genes&amp;author=NM%20Tung&amp;author=ME%20Robson&amp;author=S%20Ventz&amp;author=CA%20Santa-Maria&amp;author=R%20Nanda&amp;volume=38&amp;issue=36&amp;publication_year=2020&amp;pages=4274-82&amp;pmid=33119476&amp;doi=10.1200/JCO.20.02151&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref016">
<span class="label">16.</span><cite>Lumish HS, Steinfeld H, Koval C, Russo D, Levinson E, Wynn J, et al. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients. J Genet Couns. 2017;26(5):1116–29. doi: 10.1007/s10897-017-0090-y
</cite> [<a href="https://doi.org/10.1007/s10897-017-0090-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7250529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28357778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Genet%20Couns&amp;title=Impact%20of%20Panel%20Gene%20Testing%20for%20Hereditary%20Breast%20and%20Ovarian%20Cancer%20on%20Patients&amp;author=HS%20Lumish&amp;author=H%20Steinfeld&amp;author=C%20Koval&amp;author=D%20Russo&amp;author=E%20Levinson&amp;volume=26&amp;issue=5&amp;publication_year=2017&amp;pages=1116-29&amp;pmid=28357778&amp;doi=10.1007/s10897-017-0090-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref017">
<span class="label">17.</span><cite>Panguluri RC, Brody LC, Modali R, Utley K, Adams-Campbell L, Day AA, et al. BRCA1 mutations in African Americans. Hum Genet. 1999;105(1–2):28–31. doi: 10.1007/s004399900085
</cite> [<a href="https://doi.org/10.1007/s004399900085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10480351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Genet&amp;title=BRCA1%20mutations%20in%20African%20Americans&amp;author=RC%20Panguluri&amp;author=LC%20Brody&amp;author=R%20Modali&amp;author=K%20Utley&amp;author=L%20Adams-Campbell&amp;volume=105&amp;issue=1%E2%80%932&amp;publication_year=1999&amp;pages=28-31&amp;pmid=10480351&amp;doi=10.1007/s004399900085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref018">
<span class="label">18.</span><cite>Kanaan Y, Kpenu E, Utley K, Adams-Campbell L, Dunston GM, Brody LC, et al. Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases. Hum Genet. 2003;113(5):452–60. doi: 10.1007/s00439-003-0999-0
</cite> [<a href="https://doi.org/10.1007/s00439-003-0999-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12942367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Genet&amp;title=Inherited%20BRCA2%20mutations%20in%20African%20Americans%20with%20breast%20and/or%20ovarian%20cancer:%20a%20study%20of%20familial%20and%20early%20onset%20cases&amp;author=Y%20Kanaan&amp;author=E%20Kpenu&amp;author=K%20Utley&amp;author=L%20Adams-Campbell&amp;author=GM%20Dunston&amp;volume=113&amp;issue=5&amp;publication_year=2003&amp;pages=452-60&amp;pmid=12942367&amp;doi=10.1007/s00439-003-0999-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref019">
<span class="label">19.</span><cite>Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C. Breast cancer genetics in African Americans. Cancer. 2003;97(1 Suppl):236–45. doi: 10.1002/cncr.11019
</cite> [<a href="https://doi.org/10.1002/cncr.11019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12491487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Breast%20cancer%20genetics%20in%20African%20Americans&amp;author=OI%20Olopade&amp;author=JD%20Fackenthal&amp;author=G%20Dunston&amp;author=MA%20Tainsky&amp;author=F%20Collins&amp;volume=97&amp;issue=1&amp;publication_year=2003&amp;pages=236-45&amp;pmid=12491487&amp;doi=10.1002/cncr.11019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref020">
<span class="label">20.</span><cite>Mefford HC, Baumbach L, Panguluri RC, Whitfield-Broome C, Szabo C, Smith S, et al. Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet. 1999;65(2):575–8. doi: 10.1086/302511
</cite> [<a href="https://doi.org/10.1086/302511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1377959/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10417303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Evidence%20for%20a%20BRCA1%20founder%20mutation%20in%20families%20of%20West%20African%20ancestry&amp;author=HC%20Mefford&amp;author=L%20Baumbach&amp;author=RC%20Panguluri&amp;author=C%20Whitfield-Broome&amp;author=C%20Szabo&amp;volume=65&amp;issue=2&amp;publication_year=1999&amp;pages=575-8&amp;pmid=10417303&amp;doi=10.1086/302511&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref021">
<span class="label">21.</span><cite>McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303. doi: 10.1101/gr.107524.110
</cite> [<a href="https://doi.org/10.1101/gr.107524.110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2928508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20644199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res&amp;title=The%20Genome%20Analysis%20Toolkit:%20a%20MapReduce%20framework%20for%20analyzing%20next-generation%20DNA%20sequencing%20data&amp;author=A%20McKenna&amp;author=M%20Hanna&amp;author=E%20Banks&amp;author=A%20Sivachenko&amp;author=K%20Cibulskis&amp;volume=20&amp;issue=9&amp;publication_year=2010&amp;pages=1297-303&amp;pmid=20644199&amp;doi=10.1101/gr.107524.110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref022">
<span class="label">22.</span><cite>DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491–8. doi: 10.1038/ng.806
</cite> [<a href="https://doi.org/10.1038/ng.806" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3083463/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21478889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=A%20framework%20for%20variation%20discovery%20and%20genotyping%20using%20next-generation%20DNA%20sequencing%20data&amp;author=MA%20DePristo&amp;author=E%20Banks&amp;author=R%20Poplin&amp;author=KV%20Garimella&amp;author=JR%20Maguire&amp;volume=43&amp;issue=5&amp;publication_year=2011&amp;pages=491-8&amp;pmid=21478889&amp;doi=10.1038/ng.806&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref023">
<span class="label">23.</span><cite>Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013;43:11 0 1–0 33. doi: 10.1002/0471250953.bi1110s43
</cite> [<a href="https://doi.org/10.1002/0471250953.bi1110s43" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4243306/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25431634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Protoc%20Bioinformatics&amp;title=From%20FastQ%20data%20to%20high%20confidence%20variant%20calls:%20the%20Genome%20Analysis%20Toolkit%20best%20practices%20pipeline&amp;author=GA%20Van%20der%20Auwera&amp;author=MO%20Carneiro&amp;author=C%20Hartl&amp;author=R%20Poplin&amp;author=G%20Del%20Angel&amp;volume=43&amp;publication_year=2013&amp;pages=11&amp;pmid=25431634&amp;doi=10.1002/0471250953.bi1110s43&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref024">
<span class="label">24.</span><cite>Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589–95. doi: 10.1093/bioinformatics/btp698
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btp698" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2828108/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20080505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Fast%20and%20accurate%20long-read%20alignment%20with%20Burrows-Wheeler%20transform&amp;author=H%20Li&amp;author=R%20Durbin&amp;volume=26&amp;issue=5&amp;publication_year=2010&amp;pages=589-95&amp;pmid=20080505&amp;doi=10.1093/bioinformatics/btp698&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref025">
<span class="label">25.</span><cite>Li HW. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv: Genomics. 2013.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=arXiv:%20Genomics&amp;title=Aligning%20sequence%20reads,%20clone%20sequences%20and%20assembly%20contigs%20with%20BWA-MEM&amp;author=HW%20Li&amp;publication_year=2013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref026">
<span class="label">26.</span><cite>Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747–56. doi: 10.1101/gr.239244.118
</cite> [<a href="https://doi.org/10.1101/gr.239244.118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6211645/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30341162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res&amp;title=Maftools:%20efficient%20and%20comprehensive%20analysis%20of%20somatic%20variants%20in%20cancer&amp;author=A%20Mayakonda&amp;author=DC%20Lin&amp;author=Y%20Assenov&amp;author=C%20Plass&amp;author=HP%20Koeffler&amp;volume=28&amp;issue=11&amp;publication_year=2018&amp;pages=1747-56&amp;pmid=30341162&amp;doi=10.1101/gr.239244.118&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref027">
<span class="label">27.</span><cite>Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S, et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012;28(21):2747–54. doi: 10.1093/bioinformatics/bts526
</cite> [<a href="https://doi.org/10.1093/bioinformatics/bts526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3476336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22942019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=A%20robust%20model%20for%20read%20count%20data%20in%20exome%20sequencing%20experiments%20and%20implications%20for%20copy%20number%20variant%20calling&amp;author=V%20Plagnol&amp;author=J%20Curtis&amp;author=M%20Epstein&amp;author=KY%20Mok&amp;author=E%20Stebbings&amp;volume=28&amp;issue=21&amp;publication_year=2012&amp;pages=2747-54&amp;pmid=22942019&amp;doi=10.1093/bioinformatics/bts526&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref028">
<span class="label">28.</span><cite>Lowy-Gallego E, Fairley S, Zheng-Bradley X, Ruffier M, Clarke L, Flicek P, et al. Variant calling on the GRCh38 assembly with the data from phase three of the 1000 Genomes Project. Wellcome Open Res. 2019;4:50. doi: 10.12688/wellcomeopenres.15126.2
</cite> [<a href="https://doi.org/10.12688/wellcomeopenres.15126.2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7059836/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32175479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Wellcome%20Open%20Res&amp;title=Variant%20calling%20on%20the%20GRCh38%20assembly%20with%20the%20data%20from%20phase%20three%20of%20the%201000%20Genomes%20Project&amp;author=E%20Lowy-Gallego&amp;author=S%20Fairley&amp;author=X%20Zheng-Bradley&amp;author=M%20Ruffier&amp;author=L%20Clarke&amp;volume=4&amp;publication_year=2019&amp;pages=50&amp;pmid=32175479&amp;doi=10.12688/wellcomeopenres.15126.2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref029">
<span class="label">29.</span><cite>Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7. doi: 10.1186/s13742-015-0047-8
</cite> [<a href="https://doi.org/10.1186/s13742-015-0047-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4342193/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25722852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gigascience&amp;title=Second-generation%20PLINK:%20rising%20to%20the%20challenge%20of%20larger%20and%20richer%20datasets&amp;author=CC%20Chang&amp;author=CC%20Chow&amp;author=LC%20Tellier&amp;author=S%20Vattikuti&amp;author=SM%20Purcell&amp;volume=4&amp;publication_year=2015&amp;pages=7&amp;pmid=25722852&amp;doi=10.1186/s13742-015-0047-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref030">
<span class="label">30.</span><cite>Crossett A, Kent BP, Klei L, Ringquist S, Trucco M, Roeder K, et al. Using ancestry matching to combine family-based and unrelated samples for genome-wide association studies. Stat Med. 2010;29(28):2932–45. doi: 10.1002/sim.4057
</cite> [<a href="https://doi.org/10.1002/sim.4057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4629477/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20862653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stat%20Med&amp;title=Using%20ancestry%20matching%20to%20combine%20family-based%20and%20unrelated%20samples%20for%20genome-wide%20association%20studies&amp;author=A%20Crossett&amp;author=BP%20Kent&amp;author=L%20Klei&amp;author=S%20Ringquist&amp;author=M%20Trucco&amp;volume=29&amp;issue=28&amp;publication_year=2010&amp;pages=2932-45&amp;pmid=20862653&amp;doi=10.1002/sim.4057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref031">
<span class="label">31.</span><cite>Lee AB, Luca D, Klei L, Devlin B, Roeder K. Discovering genetic ancestry using spectral graph theory. Genet Epidemiol. 2010;34(1):51–9. doi: 10.1002/gepi.20434
</cite> [<a href="https://doi.org/10.1002/gepi.20434" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4610359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19455578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Epidemiol&amp;title=Discovering%20genetic%20ancestry%20using%20spectral%20graph%20theory&amp;author=AB%20Lee&amp;author=D%20Luca&amp;author=L%20Klei&amp;author=B%20Devlin&amp;author=K%20Roeder&amp;volume=34&amp;issue=1&amp;publication_year=2010&amp;pages=51-9&amp;pmid=19455578&amp;doi=10.1002/gepi.20434&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref032">
<span class="label">32.</span><cite>Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155(2):945–59. doi: 10.1093/genetics/155.2.945
</cite> [<a href="https://doi.org/10.1093/genetics/155.2.945" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1461096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10835412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Inference%20of%20population%20structure%20using%20multilocus%20genotype%20data&amp;author=JK%20Pritchard&amp;author=M%20Stephens&amp;author=P%20Donnelly&amp;volume=155&amp;issue=2&amp;publication_year=2000&amp;pages=945-59&amp;pmid=10835412&amp;doi=10.1093/genetics/155.2.945&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref033">
<span class="label">33.</span><cite>Kopelman NM, Mayzel J, Jakobsson M, Rosenberg NA, Mayrose I. Clumpak: a program for identifying clustering modes and packaging population structure inferences across K. Mol Ecol Resour. 2015;15(5):1179–91. doi: 10.1111/1755-0998.12387
</cite> [<a href="https://doi.org/10.1111/1755-0998.12387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4534335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25684545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ecol%20Resour&amp;title=Clumpak:%20a%20program%20for%20identifying%20clustering%20modes%20and%20packaging%20population%20structure%20inferences%20across%20K&amp;author=NM%20Kopelman&amp;author=J%20Mayzel&amp;author=M%20Jakobsson&amp;author=NA%20Rosenberg&amp;author=I%20Mayrose&amp;volume=15&amp;issue=5&amp;publication_year=2015&amp;pages=1179-91&amp;pmid=25684545&amp;doi=10.1111/1755-0998.12387&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref034">
<span class="label">34.</span><cite>Cobain EF, Milliron KJ, Merajver SD. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Semin Oncol. 2016;43(5):528–35. doi: 10.1053/j.seminoncol.2016.10.001
</cite> [<a href="https://doi.org/10.1053/j.seminoncol.2016.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27899183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Semin%20Oncol&amp;title=Updates%20on%20breast%20cancer%20genetics:%20Clinical%20implications%20of%20detecting%20syndromes%20of%20inherited%20increased%20susceptibility%20to%20breast%20cancer&amp;author=EF%20Cobain&amp;author=KJ%20Milliron&amp;author=SD%20Merajver&amp;volume=43&amp;issue=5&amp;publication_year=2016&amp;pages=528-35&amp;pmid=27899183&amp;doi=10.1053/j.seminoncol.2016.10.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref035">
<span class="label">35.</span><cite>Rainville IR, Rana HQ. Next-generation sequencing for inherited breast cancer risk: counseling through the complexity. Curr Oncol Rep. 2014;16(3):371. doi: 10.1007/s11912-013-0371-z
</cite> [<a href="https://doi.org/10.1007/s11912-013-0371-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24488544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Oncol%20Rep&amp;title=Next-generation%20sequencing%20for%20inherited%20breast%20cancer%20risk:%20counseling%20through%20the%20complexity&amp;author=IR%20Rainville&amp;author=HQ%20Rana&amp;volume=16&amp;issue=3&amp;publication_year=2014&amp;pages=371&amp;pmid=24488544&amp;doi=10.1007/s11912-013-0371-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref036">
<span class="label">36.</span><cite>Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat. 2016;160(3):393–410. doi: 10.1007/s10549-016-4003-9
</cite> [<a href="https://doi.org/10.1007/s10549-016-4003-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27734215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Time%20to%20incorporate%20germline%20multigene%20panel%20testing%20into%20breast%20and%20ovarian%20cancer%20patient%20care&amp;author=R%20Graffeo&amp;author=L%20Livraghi&amp;author=O%20Pagani&amp;author=A%20Goldhirsch&amp;author=AH%20Partridge&amp;volume=160&amp;issue=3&amp;publication_year=2016&amp;pages=393-410&amp;pmid=27734215&amp;doi=10.1007/s10549-016-4003-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref037">
<span class="label">37.</span><cite>Pilarski R.
How Have Multigene Panels Changed the Clinical Practice of Genetic Counseling and Testing. J Natl Compr Canc Netw.
2021;19(1):103–8. doi: 10.6004/jnccn.2020.7674
</cite> [<a href="https://doi.org/10.6004/jnccn.2020.7674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33406496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Compr%20Canc%20Netw.&amp;title=How%20Have%20Multigene%20Panels%20Changed%20the%20Clinical%20Practice%20of%20Genetic%20Counseling%20and%20Testing&amp;author=R.%20Pilarski&amp;volume=19&amp;issue=1&amp;publication_year=2021&amp;pages=103-8&amp;pmid=33406496&amp;doi=10.6004/jnccn.2020.7674&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref038">
<span class="label">38.</span><cite>Filippini SE, Vega A. Breast cancer genes: beyond BRCA1 and BRCA2. Front Biosci (Landmark Ed). 2013;18:1358–72. doi: 10.2741/4185
</cite> [<a href="https://doi.org/10.2741/4185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23747889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Biosci%20(Landmark%20Ed)&amp;title=Breast%20cancer%20genes:%20beyond%20BRCA1%20and%20BRCA2&amp;author=SE%20Filippini&amp;author=A%20Vega&amp;volume=18&amp;publication_year=2013&amp;pages=1358-72&amp;pmid=23747889&amp;doi=10.2741/4185&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref039">
<span class="label">39.</span><cite>Desmond A, Kurian AW, Gabree M, Mills MA, Anderson MJ, Kobayashi Y, et al. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
JAMA Oncol. 2015;1(7):943–51. doi: 10.1001/jamaoncol.2015.2690
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2015.2690" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26270727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Clinical%20Actionability%20of%20Multigene%20Panel%20Testing%20for%20Hereditary%20Breast%20and%20Ovarian%20Cancer%20Risk%20Assessment.&amp;author=A%20Desmond&amp;author=AW%20Kurian&amp;author=M%20Gabree&amp;author=MA%20Mills&amp;author=MJ%20Anderson&amp;volume=1&amp;issue=7&amp;publication_year=2015&amp;pages=943-51&amp;pmid=26270727&amp;doi=10.1001/jamaoncol.2015.2690&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref040">
<span class="label">40.</span><cite>LaDuca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T, et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med. 2014;16(11):830–7. doi: 10.1038/gim.2014.40
</cite> [<a href="https://doi.org/10.1038/gim.2014.40" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4225457/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24763289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Utilization%20of%20multigene%20panels%20in%20hereditary%20cancer%20predisposition%20testing:%20analysis%20of%20more%20than%202,000%20patients&amp;author=H%20LaDuca&amp;author=AJ%20Stuenkel&amp;author=JS%20Dolinsky&amp;author=S%20Keiles&amp;author=S%20Tandy&amp;volume=16&amp;issue=11&amp;publication_year=2014&amp;pages=830-7&amp;pmid=24763289&amp;doi=10.1038/gim.2014.40&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref041">
<span class="label">41.</span><cite>Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, et al. Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol. 2014;32(19):2001–9. doi: 10.1200/JCO.2013.53.6607
</cite> [<a href="https://doi.org/10.1200/JCO.2013.53.6607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4067941/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24733792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Clinical%20evaluation%20of%20a%20multiple-gene%20sequencing%20panel%20for%20hereditary%20cancer%20risk%20assessment&amp;author=AW%20Kurian&amp;author=EE%20Hare&amp;author=MA%20Mills&amp;author=KE%20Kingham&amp;author=L%20McPherson&amp;volume=32&amp;issue=19&amp;publication_year=2014&amp;pages=2001-9&amp;pmid=24733792&amp;doi=10.1200/JCO.2013.53.6607&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref042">
<span class="label">42.</span><cite>Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A. 2011;108(44):18032–7. doi: 10.1073/pnas.1115052108
</cite> [<a href="https://doi.org/10.1073/pnas.1115052108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3207658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22006311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Mutations%20in%2012%20genes%20for%20inherited%20ovarian,%20fallopian%20tube,%20and%20peritoneal%20carcinoma%20identified%20by%20massively%20parallel%20sequencing&amp;author=T%20Walsh&amp;author=S%20Casadei&amp;author=MK%20Lee&amp;author=CC%20Pennil&amp;author=AS%20Nord&amp;volume=108&amp;issue=44&amp;publication_year=2011&amp;pages=18032-7&amp;pmid=22006311&amp;doi=10.1073/pnas.1115052108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref043">
<span class="label">43.</span><cite>Churpek JE, Walsh T, Zheng Y, Moton Z, Thornton AM, Lee MK, et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Res Treat. 2015;149(1):31–9. doi: 10.1007/s10549-014-3195-0
</cite> [<a href="https://doi.org/10.1007/s10549-014-3195-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4298662/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25428789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Inherited%20predisposition%20to%20breast%20cancer%20among%20African%20American%20women&amp;author=JE%20Churpek&amp;author=T%20Walsh&amp;author=Y%20Zheng&amp;author=Z%20Moton&amp;author=AM%20Thornton&amp;volume=149&amp;issue=1&amp;publication_year=2015&amp;pages=31-9&amp;pmid=25428789&amp;doi=10.1007/s10549-014-3195-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref044">
<span class="label">44.</span><cite>Yurgelun MB, Allen B, Kaldate RR, Bowles KR, Judkins T, Kaushik P, et al. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. Gastroenterology. 2015;149(3):604–13 e20. doi: 10.1053/j.gastro.2015.05.006
</cite> [<a href="https://doi.org/10.1053/j.gastro.2015.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4550537/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25980754/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Identification%20of%20a%20Variety%20of%20Mutations%20in%20Cancer%20Predisposition%20Genes%20in%20Patients%20With%20Suspected%20Lynch%20Syndrome&amp;author=MB%20Yurgelun&amp;author=B%20Allen&amp;author=RR%20Kaldate&amp;author=KR%20Bowles&amp;author=T%20Judkins&amp;volume=149&amp;issue=3&amp;publication_year=2015&amp;pages=604-13&amp;pmid=25980754&amp;doi=10.1053/j.gastro.2015.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref045">
<span class="label">45.</span><cite>Roeb W, Higgins J, King MC. Response to DNA damage of CHEK2 missense mutations in familial breast cancer. Hum Mol Genet. 2012;21(12):2738–44. doi: 10.1093/hmg/dds101
</cite> [<a href="https://doi.org/10.1093/hmg/dds101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3363333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22419737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mol%20Genet&amp;title=Response%20to%20DNA%20damage%20of%20CHEK2%20missense%20mutations%20in%20familial%20breast%20cancer&amp;author=W%20Roeb&amp;author=J%20Higgins&amp;author=MC%20King&amp;volume=21&amp;issue=12&amp;publication_year=2012&amp;pages=2738-44&amp;pmid=22419737&amp;doi=10.1093/hmg/dds101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref046">
<span class="label">46.</span><cite>Minervini G, Lopreiato R, Bortolotto R, Falconieri A, Sartori G, Tosatto SCE. Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors. Sci Rep. 2017;7:46562. doi: 10.1038/srep46562
</cite> [<a href="https://doi.org/10.1038/srep46562" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5397843/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28425505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Novel%20interactions%20of%20the%20von%20Hippel-Lindau%20(pVHL)%20tumor%20suppressor%20with%20the%20CDKN1%20family%20of%20cell%20cycle%20inhibitors&amp;author=G%20Minervini&amp;author=R%20Lopreiato&amp;author=R%20Bortolotto&amp;author=A%20Falconieri&amp;author=G%20Sartori&amp;volume=7&amp;publication_year=2017&amp;pages=46562&amp;pmid=28425505&amp;doi=10.1038/srep46562&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref047">
<span class="label">47.</span><cite>Marlin R, Creoff M, Merle S, Jean-Marie-Flore M, Rose M, Malsa S, et al. Mutation HOXB13 c.853delT in Martinican prostate cancer patients. Prostate. 2020;80(6):463–70. doi: 10.1002/pros.23960
</cite> [<a href="https://doi.org/10.1002/pros.23960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32040869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Mutation%20HOXB13%20c.853delT%20in%20Martinican%20prostate%20cancer%20patients&amp;author=R%20Marlin&amp;author=M%20Creoff&amp;author=S%20Merle&amp;author=M%20Jean-Marie-Flore&amp;author=M%20Rose&amp;volume=80&amp;issue=6&amp;publication_year=2020&amp;pages=463-70&amp;pmid=32040869&amp;doi=10.1002/pros.23960&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref048">
<span class="label">48.</span><cite>Heise M, Jarzemski P, Bak A, Junkiert-Czarnecka A, Pilarska-Deltow M, Haus O. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men. Pol J Pathol. 2019;70(2):127–33. doi: 10.5114/pjp.2019.87103
</cite> [<a href="https://doi.org/10.5114/pjp.2019.87103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31556563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pol%20J%20Pathol&amp;title=G84E%20germline%20mutation%20in%20HOXB13%20gene%20is%20associated%20with%20increased%20prostate%20cancer%20risk%20in%20Polish%20men&amp;author=M%20Heise&amp;author=P%20Jarzemski&amp;author=A%20Bak&amp;author=A%20Junkiert-Czarnecka&amp;author=M%20Pilarska-Deltow&amp;volume=70&amp;issue=2&amp;publication_year=2019&amp;pages=127-33&amp;pmid=31556563&amp;doi=10.5114/pjp.2019.87103&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref049">
<span class="label">49.</span><cite>Cai Q, Wang X, Li X, Gong R, Guo X, Tang Y, et al. Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates. Oncotarget.
2015;6(39):42312–21. doi: 10.18632/oncotarget.5994
</cite> [<a href="https://doi.org/10.18632/oncotarget.5994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4747227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26517352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget.&amp;title=Germline%20HOXB13%20p.Gly84Glu%20mutation%20and%20cancer%20susceptibility:%20a%20pooled%20analysis%20of%2025%20epidemiological%20studies%20with%20145,257%20participates&amp;author=Q%20Cai&amp;author=X%20Wang&amp;author=X%20Li&amp;author=R%20Gong&amp;author=X%20Guo&amp;volume=6&amp;issue=39&amp;publication_year=2015&amp;pages=42312-21&amp;pmid=26517352&amp;doi=10.18632/oncotarget.5994&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref050">
<span class="label">50.</span><cite>Zhang L, Walsh MF, Jairam S, Mandelker D, Zhong Y, Kemel Y, et al. Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma. Hum Mutat. 2020;41(1):103–9. doi: 10.1002/humu.23900
</cite> [<a href="https://doi.org/10.1002/humu.23900" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6930334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31444830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Fumarate%20hydratase%20FH%20c.1431_1433dupAAA%20(p.Lys477dup)%20variant%20is%20not%20associated%20with%20cancer%20including%20renal%20cell%20carcinoma&amp;author=L%20Zhang&amp;author=MF%20Walsh&amp;author=S%20Jairam&amp;author=D%20Mandelker&amp;author=Y%20Zhong&amp;volume=41&amp;issue=1&amp;publication_year=2020&amp;pages=103-9&amp;pmid=31444830&amp;doi=10.1002/humu.23900&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref051">
<span class="label">51.</span><cite>Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, et al. Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet. 2003;72(2):270–80. doi: 10.1086/346094
</cite> [<a href="https://doi.org/10.1086/346094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC379222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12533788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Mutations%20in%20CHEK2%20associated%20with%20prostate%20cancer%20risk&amp;author=X%20Dong&amp;author=L%20Wang&amp;author=K%20Taniguchi&amp;author=X%20Wang&amp;author=JM%20Cunningham&amp;volume=72&amp;issue=2&amp;publication_year=2003&amp;pages=270-80&amp;pmid=12533788&amp;doi=10.1086/346094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref052">
<span class="label">52.</span><cite>Le Calvez-Kelm F, Lesueur F, Damiola F, Vallee M, Voegele C, Babikyan D, et al. Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study. Breast Cancer Res. 2011;13(1):R6. doi: 10.1186/bcr2810
</cite> [<a href="https://doi.org/10.1186/bcr2810" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3109572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21244692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=Rare,%20evolutionarily%20unlikely%20missense%20substitutions%20in%20CHEK2%20contribute%20to%20breast%20cancer%20susceptibility:%20results%20from%20a%20breast%20cancer%20family%20registry%20case-control%20mutation-screening%20study&amp;author=F%20Le%20Calvez-Kelm&amp;author=F%20Lesueur&amp;author=F%20Damiola&amp;author=M%20Vallee&amp;author=C%20Voegele&amp;volume=13&amp;issue=1&amp;publication_year=2011&amp;pages=R6&amp;pmid=21244692&amp;doi=10.1186/bcr2810&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref053">
<span class="label">53.</span><cite>Kleiblova P, Stolarova L, Krizova K, Lhota F, Hojny J, Zemankova P, et al. Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer. Int J Cancer. 2019;145(7):1782–97. doi: 10.1002/ijc.32385
</cite> [<a href="https://doi.org/10.1002/ijc.32385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31050813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=Identification%20of%20deleterious%20germline%20CHEK2%20mutations%20and%20their%20association%20with%20breast%20and%20ovarian%20cancer&amp;author=P%20Kleiblova&amp;author=L%20Stolarova&amp;author=K%20Krizova&amp;author=F%20Lhota&amp;author=J%20Hojny&amp;volume=145&amp;issue=7&amp;publication_year=2019&amp;pages=1782-97&amp;pmid=31050813&amp;doi=10.1002/ijc.32385&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref054">
<span class="label">54.</span><cite>Hall MJ, Bernhisel R, Hughes E, Larson K, Rosenthal ET, Singh NA, et al. Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers. Cancer Prev Res (Phila). 2021;14(4):433–40. doi: 10.1158/1940-6207.CAPR-20-0448
</cite> [<a href="https://doi.org/10.1158/1940-6207.CAPR-20-0448" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8026745/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33509806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Prev%20Res%20(Phila)&amp;title=Germline%20Pathogenic%20Variants%20in%20the%20Ataxia%20Telangiectasia%20Mutated%20(ATM)%20Gene%20are%20Associated%20with%20High%20and%20Moderate%20Risks%20for%20Multiple%20Cancers&amp;author=MJ%20Hall&amp;author=R%20Bernhisel&amp;author=E%20Hughes&amp;author=K%20Larson&amp;author=ET%20Rosenthal&amp;volume=14&amp;issue=4&amp;publication_year=2021&amp;pages=433-40&amp;pmid=33509806&amp;doi=10.1158/1940-6207.CAPR-20-0448&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref055">
<span class="label">55.</span><cite>Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, et al. Inherited variants of MYH associated with somatic G:C—&gt;T:A mutations in colorectal tumors. Nat Genet. 2002;30(2):227–32.</cite> [<a href="https://doi.org/10.1038/ng828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11818965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=Inherited%20variants%20of%20MYH%20associated%20with%20somatic%20G:C%E2%80%94&gt;T:A%20mutations%20in%20colorectal%20tumors&amp;author=N%20Al-Tassan&amp;author=NH%20Chmiel&amp;author=J%20Maynard&amp;author=N%20Fleming&amp;author=AL%20Livingston&amp;volume=30&amp;issue=2&amp;publication_year=2002&amp;pages=227-32&amp;pmid=11818965&amp;doi=10.1038/ng828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref056">
<span class="label">56.</span><cite>Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med. 2003;348(9):791–9. doi: 10.1056/NEJMoa025283
</cite> [<a href="https://doi.org/10.1056/NEJMoa025283" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12606733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Multiple%20colorectal%20adenomas,%20classic%20adenomatous%20polyposis,%20and%20germ-line%20mutations%20in%20MYH&amp;author=OM%20Sieber&amp;author=L%20Lipton&amp;author=M%20Crabtree&amp;author=K%20Heinimann&amp;author=P%20Fidalgo&amp;volume=348&amp;issue=9&amp;publication_year=2003&amp;pages=791-9&amp;pmid=12606733&amp;doi=10.1056/NEJMoa025283&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref057">
<span class="label">57.</span><cite>Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, et al. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017;35(10):1086–95. doi: 10.1200/JCO.2016.71.0012
</cite> [<a href="https://doi.org/10.1200/JCO.2016.71.0012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5455355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28135145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Cancer%20Susceptibility%20Gene%20Mutations%20in%20Individuals%20With%20Colorectal%20Cancer&amp;author=MB%20Yurgelun&amp;author=MH%20Kulke&amp;author=CS%20Fuchs&amp;author=BA%20Allen&amp;author=H%20Uno&amp;volume=35&amp;issue=10&amp;publication_year=2017&amp;pages=1086-95&amp;pmid=28135145&amp;doi=10.1200/JCO.2016.71.0012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref058">
<span class="label">58.</span><cite>Parker AR, Sieber OM, Shi C, Hua L, Takao M, Tomlinson IP, et al. Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair. Carcinogenesis. 2005;26(11):2010–8. doi: 10.1093/carcin/bgi166
</cite> [<a href="https://doi.org/10.1093/carcin/bgi166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15987719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=Cells%20with%20pathogenic%20biallelic%20mutations%20in%20the%20human%20MUTYH%20gene%20are%20defective%20in%20DNA%20damage%20binding%20and%20repair&amp;author=AR%20Parker&amp;author=OM%20Sieber&amp;author=C%20Shi&amp;author=L%20Hua&amp;author=M%20Takao&amp;volume=26&amp;issue=11&amp;publication_year=2005&amp;pages=2010-8&amp;pmid=15987719&amp;doi=10.1093/carcin/bgi166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref059">
<span class="label">59.</span><cite>Goto M, Shinmura K, Nakabeppu Y, Tao H, Yamada H, Tsuneyoshi T, et al. Adenine DNA glycosylase activity of 14 human MutY homolog (MUTYH) variant proteins found in patients with colorectal polyposis and cancer. Hum Mutat. 2010;31(11):E1861–74. doi: 10.1002/humu.21363
</cite> [<a href="https://doi.org/10.1002/humu.21363" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3051265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20848659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Adenine%20DNA%20glycosylase%20activity%20of%2014%20human%20MutY%20homolog%20(MUTYH)%20variant%20proteins%20found%20in%20patients%20with%20colorectal%20polyposis%20and%20cancer&amp;author=M%20Goto&amp;author=K%20Shinmura&amp;author=Y%20Nakabeppu&amp;author=H%20Tao&amp;author=H%20Yamada&amp;volume=31&amp;issue=11&amp;publication_year=2010&amp;pages=E1861-74&amp;pmid=20848659&amp;doi=10.1002/humu.21363&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref060">
<span class="label">60.</span><cite>Gao Q, Neuhausen S, Cummings S, Luce M, Olopade OI. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet. 1997;60(5):1233–6. </cite> [<a href="/articles/PMC1712427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9150171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Recurrent%20germ-line%20BRCA1%20mutations%20in%20extended%20African%20American%20families%20with%20early-onset%20breast%20cancer&amp;author=Q%20Gao&amp;author=S%20Neuhausen&amp;author=S%20Cummings&amp;author=M%20Luce&amp;author=OI%20Olopade&amp;volume=60&amp;issue=5&amp;publication_year=1997&amp;pages=1233-6&amp;pmid=9150171&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref061">
<span class="label">61.</span><cite>Natarajan P, Gold NB, Bick AG, McLaughlin H, Kraft P, Rehm HL, et al. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans. Sci Transl Med.
2016;8(364):364ra151. doi: 10.1126/scitranslmed.aag2367
</cite> [<a href="https://doi.org/10.1126/scitranslmed.aag2367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5823271/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27831900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Transl%20Med.&amp;title=Aggregate%20penetrance%20of%20genomic%20variants%20for%20actionable%20disorders%20in%20European%20and%20African%20Americans&amp;author=P%20Natarajan&amp;author=NB%20Gold&amp;author=AG%20Bick&amp;author=H%20McLaughlin&amp;author=P%20Kraft&amp;volume=8&amp;issue=364&amp;publication_year=2016&amp;pages=364ra151&amp;pmid=27831900&amp;doi=10.1126/scitranslmed.aag2367&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref062">
<span class="label">62.</span><cite>Borg A, Haile RW, Malone KE, Capanu M, Diep A, Torngren T, et al. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat. 2010;31(3):E1200–40. doi: 10.1002/humu.21202
</cite> [<a href="https://doi.org/10.1002/humu.21202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2928257/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20104584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Characterization%20of%20BRCA1%20and%20BRCA2%20deleterious%20mutations%20and%20variants%20of%20unknown%20clinical%20significance%20in%20unilateral%20and%20bilateral%20breast%20cancer:%20the%20WECARE%20study&amp;author=A%20Borg&amp;author=RW%20Haile&amp;author=KE%20Malone&amp;author=M%20Capanu&amp;author=A%20Diep&amp;volume=31&amp;issue=3&amp;publication_year=2010&amp;pages=E1200-40&amp;pmid=20104584&amp;doi=10.1002/humu.21202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref063">
<span class="label">63.</span><cite>Stegel V, Krajc M, Zgajnar J, Teugels E, De Greve J, Hocevar M, et al. The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population. BMC Med Genet. 2011;12:9. doi: 10.1186/1471-2350-12-9
</cite> [<a href="https://doi.org/10.1186/1471-2350-12-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3025939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21232165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med%20Genet&amp;title=The%20occurrence%20of%20germline%20BRCA1%20and%20BRCA2%20sequence%20alterations%20in%20Slovenian%20population&amp;author=V%20Stegel&amp;author=M%20Krajc&amp;author=J%20Zgajnar&amp;author=E%20Teugels&amp;author=J%20De%20Greve&amp;volume=12&amp;publication_year=2011&amp;pages=9&amp;pmid=21232165&amp;doi=10.1186/1471-2350-12-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref064">
<span class="label">64.</span><cite>Palmero EI, Carraro DM, Alemar B, Moreira MAM, Ribeiro-Dos-Santos A, Abe-Sandes K, et al. The germline mutational landscape of BRCA1 and BRCA2 in Brazil. Sci Rep. 2018;8(1):9188. doi: 10.1038/s41598-018-27315-2
</cite> [<a href="https://doi.org/10.1038/s41598-018-27315-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6003960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29907814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=The%20germline%20mutational%20landscape%20of%20BRCA1%20and%20BRCA2%20in%20Brazil&amp;author=EI%20Palmero&amp;author=DM%20Carraro&amp;author=B%20Alemar&amp;author=MAM%20Moreira&amp;author=A%20Ribeiro-Dos-Santos&amp;volume=8&amp;issue=1&amp;publication_year=2018&amp;pages=9188&amp;pmid=29907814&amp;doi=10.1038/s41598-018-27315-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref065">
<span class="label">65.</span><cite>Donenberg T, Ahmed H, Royer R, Zhang S, Narod SA, George S, et al. A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago. Breast Cancer Res Treat. 2016;159(1):131–8. doi: 10.1007/s10549-016-3870-4
</cite> [<a href="https://doi.org/10.1007/s10549-016-3870-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27469594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=A%20Survey%20of%20BRCA1,%20BRCA2,%20and%20PALB2%20mutations%20in%20women%20with%20breast%20cancer%20in%20Trinidad%20and%20Tobago&amp;author=T%20Donenberg&amp;author=H%20Ahmed&amp;author=R%20Royer&amp;author=S%20Zhang&amp;author=SA%20Narod&amp;volume=159&amp;issue=1&amp;publication_year=2016&amp;pages=131-8&amp;pmid=27469594&amp;doi=10.1007/s10549-016-3870-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref066">
<span class="label">66.</span><cite>Meisel C, Sadowski CE, Kohlstedt D, Keller K, Staritz F, Grubling N, et al. Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study. Arch Gynecol Obstet. 2017;295(5):1227–38. doi: 10.1007/s00404-017-4330-z
</cite> [<a href="https://doi.org/10.1007/s00404-017-4330-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28324225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Gynecol%20Obstet&amp;title=Spectrum%20of%20genetic%20variants%20of%20BRCA1%20and%20BRCA2%20in%20a%20German%20single%20center%20study&amp;author=C%20Meisel&amp;author=CE%20Sadowski&amp;author=D%20Kohlstedt&amp;author=K%20Keller&amp;author=F%20Staritz&amp;volume=295&amp;issue=5&amp;publication_year=2017&amp;pages=1227-38&amp;pmid=28324225&amp;doi=10.1007/s00404-017-4330-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref067">
<span class="label">67.</span><cite>Li H, Sisoudiya SD, Martin-Giacalone BA, Khayat MM, Dugan-Perez S, Marquez-Do DA, et al. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group. J Natl Cancer Inst. 2021;113(7):875–83. doi: 10.1093/jnci/djaa204
</cite> [<a href="https://doi.org/10.1093/jnci/djaa204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8246828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33372952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Cancer%20Inst&amp;title=Germline%20Cancer%20Predisposition%20Variants%20in%20Pediatric%20Rhabdomyosarcoma:%20A%20Report%20From%20the%20Children%E2%80%99s%20Oncology%20Group&amp;author=H%20Li&amp;author=SD%20Sisoudiya&amp;author=BA%20Martin-Giacalone&amp;author=MM%20Khayat&amp;author=S%20Dugan-Perez&amp;volume=113&amp;issue=7&amp;publication_year=2021&amp;pages=875-83&amp;pmid=33372952&amp;doi=10.1093/jnci/djaa204&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref068">
<span class="label">68.</span><cite>Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, et al. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am J Hum Genet. 2009;84(5):605–16. doi: 10.1016/j.ajhg.2009.04.010
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2009.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2681000/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19409520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Human%20RAD50%20deficiency%20in%20a%20Nijmegen%20breakage%20syndrome-like%20disorder&amp;author=R%20Waltes&amp;author=R%20Kalb&amp;author=M%20Gatei&amp;author=AW%20Kijas&amp;author=M%20Stumm&amp;volume=84&amp;issue=5&amp;publication_year=2009&amp;pages=605-16&amp;pmid=19409520&amp;doi=10.1016/j.ajhg.2009.04.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref069">
<span class="label">69.</span><cite>Tommiska J, Seal S, Renwick A, Barfoot R, Baskcomb L, Jayatilake H, et al. Evaluation of RAD50 in familial breast cancer predisposition. Int J Cancer. 2006;118(11):2911–6. doi: 10.1002/ijc.21738
</cite> [<a href="https://doi.org/10.1002/ijc.21738" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16385572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=Evaluation%20of%20RAD50%20in%20familial%20breast%20cancer%20predisposition&amp;author=J%20Tommiska&amp;author=S%20Seal&amp;author=A%20Renwick&amp;author=R%20Barfoot&amp;author=L%20Baskcomb&amp;volume=118&amp;issue=11&amp;publication_year=2006&amp;pages=2911-6&amp;pmid=16385572&amp;doi=10.1002/ijc.21738&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref070">
<span class="label">70.</span><cite>Nugent A, Conatser KR, Turner LL, Nugent JT, Sarino EMB, Ricks-Santi LJ. Reporting of race in genome and exome sequencing studies of cancer: a scoping review of the literature. Genet Med. 2019;21(12):2676–80. doi: 10.1038/s41436-019-0558-2
</cite> [<a href="https://doi.org/10.1038/s41436-019-0558-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6891161/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31160752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Reporting%20of%20race%20in%20genome%20and%20exome%20sequencing%20studies%20of%20cancer:%20a%20scoping%20review%20of%20the%20literature&amp;author=A%20Nugent&amp;author=KR%20Conatser&amp;author=LL%20Turner&amp;author=JT%20Nugent&amp;author=EMB%20Sarino&amp;volume=21&amp;issue=12&amp;publication_year=2019&amp;pages=2676-80&amp;pmid=31160752&amp;doi=10.1038/s41436-019-0558-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref071">
<span class="label">71.</span><cite>Pal T, Permuth-Wey J, Holtje T, Sutphen R. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2004;13(11 Pt 1):1794–9.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/15533909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=BRCA1%20and%20BRCA2%20mutations%20in%20a%20study%20of%20African%20American%20breast%20cancer%20patients&amp;author=T%20Pal&amp;author=J%20Permuth-Wey&amp;author=T%20Holtje&amp;author=R%20Sutphen&amp;volume=13&amp;issue=11&amp;publication_year=2004&amp;pages=1794-9&amp;pmid=15533909&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref072">
<span class="label">72.</span><cite>Newman LA. Breast cancer in African-American women. Oncologist. 2005;10(1):1–14. doi: 10.1634/theoncologist.10-1-1
</cite> [<a href="https://doi.org/10.1634/theoncologist.10-1-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15632248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncologist&amp;title=Breast%20cancer%20in%20African-American%20women&amp;author=LA%20Newman&amp;volume=10&amp;issue=1&amp;publication_year=2005&amp;pages=1-14&amp;pmid=15632248&amp;doi=10.1634/theoncologist.10-1-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref073">
<span class="label">73.</span><cite>Newman LA. Breast cancer disparities: high-risk breast cancer and African ancestry. Surg Oncol Clin N Am. 2014;23(3):579–92. doi: 10.1016/j.soc.2014.03.014
</cite> [<a href="https://doi.org/10.1016/j.soc.2014.03.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24882352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Surg%20Oncol%20Clin%20N%20Am&amp;title=Breast%20cancer%20disparities:%20high-risk%20breast%20cancer%20and%20African%20ancestry&amp;author=LA%20Newman&amp;volume=23&amp;issue=3&amp;publication_year=2014&amp;pages=579-92&amp;pmid=24882352&amp;doi=10.1016/j.soc.2014.03.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref074">
<span class="label">74.</span><cite>Yamano T, Nishimasu H, Zetsche B, Hirano H, Slaymaker IM, Li Y, et al. Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA. Cell. 2016;165(4):949–62. doi: 10.1016/j.cell.2016.04.003
</cite> [<a href="https://doi.org/10.1016/j.cell.2016.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4899970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27114038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Crystal%20Structure%20of%20Cpf1%20in%20Complex%20with%20Guide%20RNA%20and%20Target%20DNA&amp;author=T%20Yamano&amp;author=H%20Nishimasu&amp;author=B%20Zetsche&amp;author=H%20Hirano&amp;author=IM%20Slaymaker&amp;volume=165&amp;issue=4&amp;publication_year=2016&amp;pages=949-62&amp;pmid=27114038&amp;doi=10.1016/j.cell.2016.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref075">
<span class="label">75.</span><cite>Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, et al. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. JAMA Oncol. 2021;7(2):230–7. doi: 10.1001/jamaoncol.2020.6252
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2020.6252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7600058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33126242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Comparison%20of%20Universal%20Genetic%20Testing%20vs%20Guideline-Directed%20Targeted%20Testing%20for%20Patients%20With%20Hereditary%20Cancer%20Syndrome&amp;author=NJ%20Samadder&amp;author=D%20Riegert-Johnson&amp;author=L%20Boardman&amp;author=D%20Rhodes&amp;author=M%20Wick&amp;volume=7&amp;issue=2&amp;publication_year=2021&amp;pages=230-7&amp;pmid=33126242&amp;doi=10.1001/jamaoncol.2020.6252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref076">
<span class="label">76.</span><cite>Li H, LaDuca H, Pesaran T, Chao EC, Dolinsky JS, Parsons M, et al. Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort. Genet Med. 2020;22(4):701–8. doi: 10.1038/s41436-019-0729-1
</cite> [<a href="https://doi.org/10.1038/s41436-019-0729-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7118020/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31853058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Classification%20of%20variants%20of%20uncertain%20significance%20in%20BRCA1%20and%20BRCA2%20using%20personal%20and%20family%20history%20of%20cancer%20from%20individuals%20in%20a%20large%20hereditary%20cancer%20multigene%20panel%20testing%20cohort&amp;author=H%20Li&amp;author=H%20LaDuca&amp;author=T%20Pesaran&amp;author=EC%20Chao&amp;author=JS%20Dolinsky&amp;volume=22&amp;issue=4&amp;publication_year=2020&amp;pages=701-8&amp;pmid=31853058&amp;doi=10.1038/s41436-019-0729-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref077">
<span class="label">77.</span><cite>Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn.
2017;19(1):4–23. doi: 10.1016/j.jmoldx.2016.10.002
</cite> [<a href="https://doi.org/10.1016/j.jmoldx.2016.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5707196/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27993330/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Mol%20Diagn.&amp;title=Standards%20and%20Guidelines%20for%20the%20Interpretation%20and%20Reporting%20of%20Sequence%20Variants%20in%20Cancer:%20A%20Joint%20Consensus%20Recommendation%20of%20the%20Association%20for%20Molecular%20Pathology,%20American%20Society%20of%20Clinical%20Oncology,%20and%20College%20of%20American%20Pathologists&amp;author=MM%20Li&amp;author=M%20Datto&amp;author=EJ%20Duncavage&amp;author=S%20Kulkarni&amp;author=NI%20Lindeman&amp;volume=19&amp;issue=1&amp;publication_year=2017&amp;pages=4-23&amp;pmid=27993330&amp;doi=10.1016/j.jmoldx.2016.10.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref078">
<span class="label">78.</span><cite>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi: 10.1038/gim.2015.30
</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20a%20joint%20consensus%20recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S%20Richards&amp;author=N%20Aziz&amp;author=S%20Bale&amp;author=D%20Bick&amp;author=S%20Das&amp;volume=17&amp;issue=5&amp;publication_year=2015&amp;pages=405-24&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref079">
<span class="label">79.</span><cite>Ha HI, Ryu JS, Shim H, Kong SY, Lim MC. Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers. J Gynecol Oncol. 2020;31(6):e83. doi: 10.3802/jgo.2020.31.e83
</cite> [<a href="https://doi.org/10.3802/jgo.2020.31.e83" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7593220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33078592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Gynecol%20Oncol&amp;title=Reclassification%20of%20BRCA1%20and%20BRCA2%20variants%20found%20in%20ovarian%20epithelial,%20fallopian%20tube,%20and%20primary%20peritoneal%20cancers&amp;author=HI%20Ha&amp;author=JS%20Ryu&amp;author=H%20Shim&amp;author=SY%20Kong&amp;author=MC%20Lim&amp;volume=31&amp;issue=6&amp;publication_year=2020&amp;pages=e83&amp;pmid=33078592&amp;doi=10.3802/jgo.2020.31.e83&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref080">
<span class="label">80.</span><cite>Park JS, Nam EJ, Park HS, Han JW, Lee JY, Kim J, et al. Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls. Cancer Res Treat. 2017;49(4):1012–21. doi: 10.4143/crt.2016.433
</cite> [<a href="https://doi.org/10.4143/crt.2016.433" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5654176/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28111427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res%20Treat&amp;title=Identification%20of%20a%20Novel%20BRCA1%20Pathogenic%20Mutation%20in%20Korean%20Patients%20Following%20Reclassification%20of%20BRCA1%20and%20BRCA2%20Variants%20According%20to%20the%20ACMG%20Standards%20and%20Guidelines%20Using%20Relevant%20Ethnic%20Controls&amp;author=JS%20Park&amp;author=EJ%20Nam&amp;author=HS%20Park&amp;author=JW%20Han&amp;author=JY%20Lee&amp;volume=49&amp;issue=4&amp;publication_year=2017&amp;pages=1012-21&amp;pmid=28111427&amp;doi=10.4143/crt.2016.433&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref081">
<span class="label">81.</span><cite>So MK, Jeong TD, Lim W, Moon BI, Paik NS, Kim SC, et al. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines. Breast Cancer. 2019;26(4):510–9. doi: 10.1007/s12282-019-00951-w
</cite> [<a href="https://doi.org/10.1007/s12282-019-00951-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30725392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer&amp;title=Reinterpretation%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance%20in%20patients%20with%20hereditary%20breast/ovarian%20cancer%20using%20the%20ACMG/AMP%202015%20guidelines&amp;author=MK%20So&amp;author=TD%20Jeong&amp;author=W%20Lim&amp;author=BI%20Moon&amp;author=NS%20Paik&amp;volume=26&amp;issue=4&amp;publication_year=2019&amp;pages=510-9&amp;pmid=30725392&amp;doi=10.1007/s12282-019-00951-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref082">
<span class="label">82.</span><cite>Wright M, Menon V, Taylor L, Shashidharan M, Westercamp T, Ternent CA. Factors predicting reclassification of variants of unknown significance. Am J Surg. 2018;216(6):1148–54. doi: 10.1016/j.amjsurg.2018.08.008
</cite> [<a href="https://doi.org/10.1016/j.amjsurg.2018.08.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30217367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Surg&amp;title=Factors%20predicting%20reclassification%20of%20variants%20of%20unknown%20significance&amp;author=M%20Wright&amp;author=V%20Menon&amp;author=L%20Taylor&amp;author=M%20Shashidharan&amp;author=T%20Westercamp&amp;volume=216&amp;issue=6&amp;publication_year=2018&amp;pages=1148-54&amp;pmid=30217367&amp;doi=10.1016/j.amjsurg.2018.08.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref083">
<span class="label">83.</span><cite>Turner SA, Rao SK, Morgan RH, Vnencak-Jones CL, Wiesner GL. The impact of variant classification on the clinical management of hereditary cancer syndromes. Genet Med. 2019;21(2):426–30. doi: 10.1038/s41436-018-0063-z
</cite> [<a href="https://doi.org/10.1038/s41436-018-0063-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29875428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=The%20impact%20of%20variant%20classification%20on%20the%20clinical%20management%20of%20hereditary%20cancer%20syndromes&amp;author=SA%20Turner&amp;author=SK%20Rao&amp;author=RH%20Morgan&amp;author=CL%20Vnencak-Jones&amp;author=GL%20Wiesner&amp;volume=21&amp;issue=2&amp;publication_year=2019&amp;pages=426-30&amp;pmid=29875428&amp;doi=10.1038/s41436-018-0063-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref084">
<span class="label">84.</span><cite>Monteiro AN, Bouwman P, Kousholt AN, Eccles DM, Millot GA, Masson JY, et al. Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation. J Med Genet. 2020;57(8):509–18. doi: 10.1136/jmedgenet-2019-106368
</cite> [<a href="https://doi.org/10.1136/jmedgenet-2019-106368" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7390672/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32152249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Variants%20of%20uncertain%20clinical%20significance%20in%20hereditary%20breast%20and%20ovarian%20cancer%20genes:%20best%20practices%20in%20functional%20analysis%20for%20clinical%20annotation&amp;author=AN%20Monteiro&amp;author=P%20Bouwman&amp;author=AN%20Kousholt&amp;author=DM%20Eccles&amp;author=GA%20Millot&amp;volume=57&amp;issue=8&amp;publication_year=2020&amp;pages=509-18&amp;pmid=32152249&amp;doi=10.1136/jmedgenet-2019-106368&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref085">
<span class="label">85.</span><cite>Boonen R, Rodrigue A, Stoepker C, Wiegant WW, Vroling B, Sharma M, et al. Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2. Nat Commun.
2019;10(1):5296. doi: 10.1038/s41467-019-13194-2
</cite> [<a href="https://doi.org/10.1038/s41467-019-13194-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6876638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31757951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun.&amp;title=Functional%20analysis%20of%20genetic%20variants%20in%20the%20high-risk%20breast%20cancer%20susceptibility%20gene%20PALB2&amp;author=R%20Boonen&amp;author=A%20Rodrigue&amp;author=C%20Stoepker&amp;author=WW%20Wiegant&amp;author=B%20Vroling&amp;volume=10&amp;issue=1&amp;publication_year=2019&amp;pages=5296&amp;pmid=31757951&amp;doi=10.1038/s41467-019-13194-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref086">
<span class="label">86.</span><cite>Wiltshire T, Ducy M, Foo TK, Hu C, Lee KY, Belur Nagaraj A, et al. Functional characterization of 84 PALB2 variants of uncertain significance. Genet Med. 2020;22(3):622–32. doi: 10.1038/s41436-019-0682-z
</cite> [<a href="https://doi.org/10.1038/s41436-019-0682-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7056643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31636395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Functional%20characterization%20of%2084%20PALB2%20variants%20of%20uncertain%20significance&amp;author=T%20Wiltshire&amp;author=M%20Ducy&amp;author=TK%20Foo&amp;author=C%20Hu&amp;author=KY%20Lee&amp;volume=22&amp;issue=3&amp;publication_year=2020&amp;pages=622-32&amp;pmid=31636395&amp;doi=10.1038/s41436-019-0682-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref087">
<span class="label">87.</span><cite>Kweon J, Jang AH, Shin HR, See JE, Lee W, Lee JW, et al. A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants. Oncogene. 2020;39(1):30–5. doi: 10.1038/s41388-019-0968-2
</cite> [<a href="https://doi.org/10.1038/s41388-019-0968-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6937211/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31467430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=A%20CRISPR-based%20base-editing%20screen%20for%20the%20functional%20assessment%20of%20BRCA1%20variants&amp;author=J%20Kweon&amp;author=AH%20Jang&amp;author=HR%20Shin&amp;author=JE%20See&amp;author=W%20Lee&amp;volume=39&amp;issue=1&amp;publication_year=2020&amp;pages=30-5&amp;pmid=31467430&amp;doi=10.1038/s41388-019-0968-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0273835.ref088">
<span class="label">88.</span><cite>Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, et al. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell. 2018;173(2):371–85 e18. doi: 10.1016/j.cell.2018.02.060
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.02.060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6029450/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29625053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Comprehensive%20Characterization%20of%20Cancer%20Driver%20Genes%20and%20Mutations&amp;author=MH%20Bailey&amp;author=C%20Tokheim&amp;author=E%20Porta-Pardo&amp;author=S%20Sengupta&amp;author=D%20Bertrand&amp;volume=173&amp;issue=2&amp;publication_year=2018&amp;pages=371-85&amp;pmid=29625053&amp;doi=10.1016/j.cell.2018.02.060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="pone.0273835.r001"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0273835.r001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0273835.r001</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 0</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Alvaro Galli</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Alvaro Galli</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alvaro Galli</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Alvaro Galli</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.c" class="d-panel p" style="display: none">
<div>© 2022 Alvaro Galli</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>18 Apr 2022</em>
</p>
<p>PONE-D-22-08035Hereditary variants of unknown significance in African American women with breast cancerPLOS ONE</p>
<p>Dear Dr. Ricks-Santi,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Jun 02 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span>. When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a>.</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Alvaro Galli</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at </p>
<p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and </p>
<p>
<a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>
</p>
<p>2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.</p>
<p>If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.</p>
<p>3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. </p>
<p>When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.</p>
<p>4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. </p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>

<strong>Comments to the Author</strong>
</p>
<p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
<p>Reviewer #1: Partly</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>2. Has the statistical analysis been performed appropriately and rigorously? </p>
<p>Reviewer #1: N/A</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>5. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: The manuscript by McDonald and Ricks-Santi evaluates targeted (DNA-repair gene) sequencing findings from 37 women with breast cancer and 51 family members from study cohorts of African American women. This is a fairly straightforward study that characterizes the findings of 85 cancer-related genes from an exome study. The results are not surprising with most sequence variants being identified as benign or VUS and a small proportion (6/37; 16% or 6 of 87—not clear from the text) of the women in this study had a pathogenic variant. There was some missing critical information in the manuscript about the cancer diagnosed in the families, characteristics about the family history and probands, how and many of the variants found were shared across family members. The rationale for including genes that are not associated with hereditary breast cancer through large studies is unclear. Points to be addressed are as follows:</p>
<p>Major:</p>
<p>This is called a high-risk cohort by the authors. Why? What is the definition of high-risk used for this study? (e.g. Were all the women with breast cancer diagnosed under the age of 50?) A definition of family history should also be included.</p>
<p>More description on the 37 women with breast cancer should be included such as age of onset and ER/PR/HER2 status of the breast cancer.</p>
<p>More description on the family members sequenced should be included. Were these affected family members, unaffected or a mix? If affected, did they have cancers other than breast? How many of them shared pathogenic/likely pathogenic variants with the 37 women?</p>
<p>It is not clear from the description of the analysis if analysis was able to detect large copy number changes. This should be noted in the results and discussion and if no copy number changes were identified on analysis this should also be included.</p>
<p>Color Genomics has a database in which variants as well as self-reported race are captured. Have any of the VUS in this study been identified in women of African ancestry? Are any of them unique to individuals with African ancestry in women with cancer or health women and if so what is the allele frequency?</p>
<p>For the conflicting variants, have any been assessed by a ClinVar expert panel or have they been evaluated in BRCAexchange? These calls may have more “weight” than earlier lab reports. That information could go into Figure 3.</p>
<p>A supplement table(s) listing all the variants found in the study, not just the VUS, should be included.</p>
<p>A number of genes included (such as HOXB13, FH) are not considered to be breast cancer susceptibility genes and PVs within these genes do not increase breast cancer risk. It is not clear why these would be included (unless the family history has a lot of other cancers). What do the data look like when ONLY breast cancer related susceptibility genes are included? (Path/LP, VUS, Benign/LB).</p>
<p>The exome sequence data for these 85 genes should be made available (e.g. deposited into dbGAP).</p>
<p>Minor:</p>
<p>Gene names should be italicized.</p>
<p>The term “mutation” (and deleterious mutation) should be replaced with “pathogenic variant”.</p>
<p>Line 70. Would read better as “the role of BRCA1/2 in…”</p>
<p>Lines 176-178. The sentence needs editing. “This variant is located in the forkhead-associated (FHA) functional domain of CHEK2 177 and while it has been found to impair DNA repair activity in yeast [38, 41].</p>
<p>Reviewer #2: Disease history (other cancers, age, bilateral, and etc) of probands and cancer types of family members would be presented for explanation of low frequency of pathogenic varinat in this study group. Also it would be need to represent comparable study results for frequencies of PV, VUS, and benign variants</p>
<p>**********</p>
<p>6. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a>.</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: No</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span>. Please note that Supporting Information files do not need this step.</p></section></article><article class="sub-article" id="pone.0273835.r002"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2022 Oct 31;17(10):e0273835. doi: <a href="https://doi.org/10.1371/journal.pone.0273835.r002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0273835.r002</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 0</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.d" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.d" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.d" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub2" class="history"><p>Collection date 2022.</p></section></div></div>
<div id="clp_a.d" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>8 Jul 2022</em>
</p>
<p>We would like to thank the reviewers for their comments. Below, we have responded to each of the concerns raised. </p>
<p>Reviewer #1:There was some missing critical information in the manuscript about the cancer diagnosed in the families, characteristics about the family history and probands, how and many of the variants found were shared across family members. The rationale for including genes that are not associated with hereditary breast cancer through large studies is unclear. Points to be addressed are as follows:</p>
<p>Major:</p>
<p>This is called a high-risk cohort by the authors. Why? What is the definition of high-risk used for this study? (e.g. Were all the women with breast cancer diagnosed under the age of 50?) A definition of family history should also be included.</p>
<p>This family-case-control study was developed at the Howard University Cancer Center, a historically black university, and funded by the National Cancer Institute. </p>
<p>The following definition of high-risk and family history is now included in the Methods section (lines 112-116):</p>
<p>“Eligibility for this study included meeting one or more of the following criteria: 1) having multiple cases (≥2) of breast or ovarian cancer in the family; 2) having early onset breast cancer (≤40 years old); 3) having bilateral breast cancer; 4) having breast and ovarian cancer in the same individual, or 5) having male breast cancer in the family. Positive family history was defined as having multiple cases (≥2) of breast or ovarian cancer in the same side of the family.” </p>
<p>More description on the 37 women with breast cancer should be included such as age of onset and ER/PR/HER2 status of the breast cancer.</p>
<p>Unfortunately, additional status such as ER/PR/HER2 is not available for the 37 women with breast cancer. The mean age was available and has been added in the Methods section (lines 141-143). The mean age for the probands, unaffected family members and affected family members was 53.76±14.25, 48.80±16.45, and 41.2±8.67, respectively. </p>
<p>More description on the family members sequenced should be included. Were these affected family members, unaffected or a mix? </p>
<p>These individuals represent affected probands (n=37) and/or their affected and/or unaffected family members (n=51). </p>
<p>If affected, did they have cancers other than breast? </p>
<p>Eleven cases reported family histories of other cancers including, but not limited to lung, colorectal, and uterine cancer.</p>
<p>How many of them shared pathogenic/likely pathogenic variants with the 37 women? </p>
<p>Three of the pathogenic/likely-pathogenic variants were found in 3 of the 37 cases. To make this clear, we have added a column in Table 1 stating if the variant was from a proband or family member. </p>
<p>It is not clear from the description of the analysis if analysis was able to detect large copy number changes. This should be noted in the results and discussion and if no copy number changes were identified on analysis this should also be included. </p>
<p>Genome copy number variation (gCNV) has now been run and is available in the new S2 Table. There was minimal impact of gCNV on the resulting variants. Only 9 of 993 variants (0.01%) had a detectable change in gCNV in two genes (7 variants in POLE and 2 variants in RECQL4). Only two of these variants with gCNV were classified VUSs and were both in the POLE gene. The remaining 7 variants were classified as benign or likely-benign.</p>
<p>Color Genomics has a database in which variants as well as self-reported race are captured. Have any of the VUS in this study been identified in women of African ancestry? Are any of them unique to individuals with African ancestry in women with cancer or health women and if so what is the allele frequency? </p>
<p>We added the allele frequencies from standard and open access datasets from the 1000 Genomes Project, NHLBI GO Exome Sequencing Project (ESP), and Genome Aggregation Database (gnomAD). This data is now shown in the new S2 Table. This data includes allele frequencies from individuals with African ancestry as well as other ancestry populations. For the VUSs, there were 19 of 170 (11.2%) that did not have a reported allele frequency in these databases. </p>
<p>For the conflicting variants, have any been assessed by a ClinVar expert panel or have they been evaluated in BRCAexchange? These calls may have more “weight” than earlier lab reports. That information could go into Figure 3.</p>
<p>There were 12 VUSs in the BRCA1 or BRCA2, however BRCAexchange lists each of these variants as “not yet reviewed”. For the ClinVar review, there were only 2 of 170 variants that were reviewed by an expert panel, both of which had a low consensus score (0 or 1, on a scale up to 9) provided in Figure 3 and S1 Table. Information on the review status provided by ClinVar has now been added to the S1 Table.</p>
<p>A supplement table(s) listing all the variants found in the study, not just the VUS, should be included.</p>
<p>The new S2 Table now includes a list of the 993 variants found in this study.</p>
<p>A number of genes included (such as HOXB13, FH) are not considered to be breast cancer susceptibility genes and PVs within these genes do not increase breast cancer risk. It is not clear why these would be included (unless the family history has a lot of other cancers). What do the data look like when ONLY breast cancer related susceptibility genes are included? (Path/LP, VUS, Benign/LB). </p>
<p>As the full dataset of variants is now provided in S2 Table, a specific comparison of the results including only breast cancer susceptibility genes can be created if necessary. </p>
<p>However, a focus of this manuscript was to not only assess genes that were associated with breast cancer, but those that are available through commercially targeted cancer sequencing panels. Genes such as HOXB13 and FH are available on these multi-cancer panels. This was due to a concern that the breast cancer panels may have been developed and tested without the inclusion of a diverse population cohort. In fact, even while looking at these broad multi-cancer panels, there is a potentially limited utility for diverse populations such as for the African American women included here. </p>
<p>As presented in the results section, genes such as HOXB13 and FH have been associated with other cancers. However, these populations were either of European descent or not reported. For example, the HOXB13 p.G84E variant was found not to be associated with breast cancer in women with European ancestry and was not detected in African or Asian populations (PMID: 32546843). However, the authors also acknowledge the sample size for individuals with African ancestry was limiting. Finally, during review of this manuscript, the African ancestry-specific occurrence of the X285K variant in HOXB13 was found to be associated with aggressive prostate cancer at an early age (PMID: 34799695).</p>
<p>The exome sequence data for these 85 genes should be made available (e.g. deposited into dbGAP). </p>
<p>Exome data has been submitted to dbGAP.</p>
<p>Minor:</p>
<p>Gene names should be italicized.</p>
<p>All gene names are now italicized.</p>
<p>The term “mutation” (and deleterious mutation) should be replaced with “pathogenic variant”.</p>
<p>The term “mutation” was replaced with “variant” throughout the manuscript.</p>
<p>Line 70. Would read better as “the role of BRCA1/2 in…”</p>
<p>This has been changed as suggested as follows: “The role of BRCA1/2 in therapeutic regimens has emerged based on the DNA repair of double stranded breaks”</p>
<p>Lines 176-178. The sentence needs editing. “This variant is located in the forkhead-associated (FHA) functional domain of CHEK2 177 and while it has been found to impair DNA repair activity in yeast [38, 41].</p>
<p>This has been edited as follows: “This variant is located in the forkhead-associated (FHA) functional domain of CHEK2 and was found to impair DNA repair activity in yeast [38, 41].”</p>
<p>Reviewer #2: Disease history (other cancers, age, bilateral, and etc) of probands and cancer types of family members would be presented for explanation of low frequency of pathogenic varinat in this study group. Also it would be need to represent comparable study results for frequencies of PV, VUS, and benign variants</p>
<p>Similar points were also raised by reviewer 1. We have now modified the manuscript to include the following definition of family history and the inclusion criteria for high-risk individuals:</p>
<p>“Eligibility for this study included meeting one or more of the following criteria: 1) having multiple cases (≥2) of breast or ovarian cancer in the family; 2) having early onset breast cancer (≤40 years old); 3) having bilateral breast cancer; 4) having breast and ovarian cancer in the same individual, or 5) having male breast cancer in the family. Positive family history was defined as having multiple cases (≥2) of breast or ovarian cancer in the same side of the family.” The mean age for the probands, unaffected family members and affected family members were 52.3±15.5, 47.80±16.7, and 41.1±9.1, respectively. And, eleven cases reported personal histories of other cancers including, but not limited to lung, colorectal, and uterine cancer. </p>
<p>Supplemental table 2 demonstrates frequencies in our population, 1000 Genomes Project, NHLBI GO Exome Sequencing Project (ESP), and Genome Aggregation Database (gnomAD).</p>
<section class="sm xbox font-sm" id="pone.0273835.s003"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9621418/bin/pone.0273835.s003.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (26.2KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0273835.r003"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0273835.r003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0273835.r003</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Alvaro Galli</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Alvaro Galli</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alvaro Galli</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.e" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.e" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.e" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Alvaro Galli</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.e" class="d-panel p" style="display: none">
<div>© 2022 Alvaro Galli</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>9 Aug 2022</em>
</p>
<p>PONE-D-22-08035R1Hereditary variants of unknown significance in African American women with breast cancerPLOS ONE</p>
<p>Dear Dr. Ricks-Santi,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Sep 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span>. When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a>.</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Alvaro Galli</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>

<strong>Comments to the Author</strong>
</p>
<p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.</p>
<p>Reviewer #1: (No Response)</p>
<p>**********</p>
<p>2. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>3. Has the statistical analysis been performed appropriately and rigorously? </p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: The authors have addressed all of my previous concerns. There are only 2 minor points to address.</p>
<p>1. In Table 1, the authors should replace SNP with missense. SNP suggests that the change is a benign polymorphism whereas missense more accurately describes the type of change.</p>
<p>2. the dbGAP accession number should be included in the manuscript.</p>
<p>**********</p>
<p>7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a>.</p>
<p>Reviewer #1: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span>. Please note that Supporting Information files do not need this step.</p></section></article><article class="sub-article" id="pone.0273835.r004"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2022 Oct 31;17(10):e0273835. doi: <a href="https://doi.org/10.1371/journal.pone.0273835.r004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0273835.r004</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 1</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.f" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.f" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.f" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub4" class="history"><p>Collection date 2022.</p></section></div></div>
<div id="clp_a.f" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>12 Aug 2022</em>
</p>
<p>We would like to thank the reviewers for their comments. Below, we have responded (in red) to each of the concerns raised. </p>
<p>Reviewer #1: The authors have addressed all of my previous concerns. There are only 2 minor points to address.</p>
<p>1. In Table 1, the authors should replace SNP with missense. SNP suggests that the change is a benign polymorphism whereas missense more accurately describes the type of change.</p>
<p>The change has been made.</p>
<p>2. the dbGAP accession number should be included in the manuscript.</p>
<p>The accession number (phs002977) was added at line 112 of the document with no track changes.</p>
<section class="sm xbox font-sm" id="pone.0273835.s004"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers 8_12_2022.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9621418/bin/pone.0273835.s004.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (20.2KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0273835.r005"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0273835.r005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0273835.r005</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 2</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Alvaro Galli</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Alvaro Galli</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alvaro Galli</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.g" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.g" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.g" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Alvaro Galli</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.g" class="d-panel p" style="display: none">
<div>© 2022 Alvaro Galli</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>17 Aug 2022</em>
</p>
<p>Hereditary variants of unknown significance in African American women with breast cancer</p>
<p>PONE-D-22-08035R2</p>
<p>Dear Dr. Ricks-Santi,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <a href="http://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.editorialmanager.com/pone/</a>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <span>authorbilling@plos.org</span>.</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <span>onepress@plos.org</span>.</p>
<p>Kind regards,</p>
<p>Alvaro Galli</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>

<strong>Comments to the Author</strong>
</p>
<p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.</p>
<p>Reviewer #1: All comments have been addressed</p>
<p>**********</p>
<p>2. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>3. Has the statistical analysis been performed appropriately and rigorously? </p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: (No Response)</p>
<p>**********</p>
<p>7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a>.</p>
<p>Reviewer #1: No</p>
<p>**********</p></section></article><article class="sub-article" id="pone.0273835.r006"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0273835.r006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0273835.r006</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Acceptance letter</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Alvaro Galli</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Alvaro Galli</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galli%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alvaro Galli</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.h" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.h" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.h" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Alvaro Galli</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.h" class="d-panel p" style="display: none">
<div>© 2022 Alvaro Galli</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>21 Oct 2022</em>
</p>
<p>PONE-D-22-08035R2 </p>
<p>Hereditary variants of unknown significance in African American women with breast cancer </p>
<p>Dear Dr. Ricks-Santi:</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p>
<p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <span>onepress@plos.org</span>.</p>
<p>If we can help with anything else, please email us at <span>plosone@plos.org</span>. </p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
<p>Kind regards, </p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Alvaro Galli </p>
<p>Academic Editor</p>
<p>PLOS ONE</p></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Table. Variants with an unknown significance or conflicting interpretation of clinical significance.</span><p>VUSs (N = 170) from the targeted regions of 85 genes with a tallied consensus score for 9 <em>in silico</em> prediction algorithms. The review status definition was provided by ClinVar as follows: (3) reviewed by expert panel, (2) two or more submitters with assertion criteria and evidence provided the same interpretation, or (1) multiple submitters provided assertion criteria and evidence but there are conflicting interpretations.</p>
<p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9621418/bin/pone.0273835.s001.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (22.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 Table. Allele frequencies for all the variants found in the targeted regions of 85 genes (N = 993).</span><p>The total and population specific allele frequencies (AF) for the current study (N = 88), 1000 Genomes Project, NHLBI GO Exome Sequencing Project (ESP), and Genome Aggregation Database (gnomAD) are shown. Genomic copy number analysis (gCNV) was calculated using ExomeDepth.</p>
<p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9621418/bin/pone.0273835.s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (199.3KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9621418/bin/pone.0273835.s003.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (26.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response to Reviewers 8_12_2022.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9621418/bin/pone.0273835.s004.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (20.2KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>All relevant data are within the paper and its <a href="#sec013" class="usa-link">Supporting Information</a> files. Exome data were also deposited in dbGAP (phs002977).</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS ONE are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0273835"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0273835.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9621418/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9621418/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9621418%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9621418/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9621418/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9621418/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/36315513/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9621418/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/36315513/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9621418/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9621418/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Hn4h7usnt4h76Nz8VEn7d2YnwHI9IfdAjxuuTmVVKMLrhT49bDLHKaR3Dz7mL0I5">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
